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3ABSTRACT 
Schizophrenia is a severe psychiatric illness that affects 1% of the world 
population. It is a brain disease manifesting in disruptions in the normal 
functioning of the human mind. Although schizophrenia has an evidenced genetic 
basis, the etiology of this complex disorder remains elusive. In addition to 
psychotic symptoms, cognitive dysfunction is one of the core symptoms of 
schizophrenia. Schizophrenia patients have impaired attention, memory and 
executive functioning, which are associated with the psychosocial consequences 
generally observed among the patients. The same dysfunctions, albeit in an 
attenuated form, may be present in some unaffected relatives of the patients, too.  
Cognitive dysfunctions have been considered as one type of biological markers, 
or endophenotypes, that confer the vulnerability of the disorder and may be 
associated with the same genetic factors as the disorder. Based on this 
assumption, this thesis examined the neuropsychological functioning of a 
representative sample of schizophrenia patients and their family members. The 
aims of the study were to estimate the heritability of the cognitive traits and to 
evaluate the number of their contributing loci. Furthermore, the study aimed at 
detecting the effects of familial loading on the dysfunctions among the unaffected 
relatives of the patients, examinining the effect of age of onset and some other 
illness factors on cognition, and evaluating whether familial loading mediates the 
observed effects. In this way exploring the value of cognitive traits as 
endophenotypic markers, the study aimed at using them in a genomewide genetic 
linkage analysis to see whether this modeling would prove valid for the search of 
genes for the disorder. In order to detect more homogeneous subgroups for 
further genetic research, the study also aimed at identifying clusters of families 
with schizophrenia that show convergent cognitive functioning.  
Impairment of several cognitive functions was heritable, such as dysfunction in 
visual working memory that also showed familial effects among both the patients, 
irrespective of the age of onset or chronicity of the illness, and the unaffected 
relatives. Verbal memory functions were observed to be contributed by several loci. 
In the genomewide linkage analysis, visual working memory showed suggestive 
linkage to chromosome 2q, and verbal memory functions showed at least modestly 
significant linkage to several markers on chromosome 4q. In the cluster analysis, 
three family groups were detected, among them one cluster with particularly poor 
cognitive performance among both the patients and relatives. 
4In conclusion, the results of the study suggested that the cognitive dysfunction 
observed in schizophrenia patients and their relatives is heritable and shows 
familial effects. The usability and validity of certain continuous cognitive traits, 
particularly verbal memory functions and visual working memory, was supported 
by the accentuated linkage evidence when compared with that previously 
detected in linkage analyses using the dichotomous diagnosis as the phenotype. 
Further studies may benefit from the results of the cluster analysis and include 
more homogeneous family groups in the analyses.    
5TIIVISTELMÄ  
Skitsofreniaan liittyvien kognitiivisten häiriöiden perinnöllisyydestä ja niiden 
esiintyvyydestä skitsofreniaa sairastavien perheissä. Helsingin yliopisto, 
psykologian laitos, 2005.  
Skitsofrenia on vakava mielenterveyden häiriö, jota esiintyy noin yhdellä 
prosentilla koko maailman väestöstä. Vaikka geneettiset tekijät ovat skitsofrenian 
synnyssä  keskeisiä, tämän monitekijäisen sairauden syytekijöitä ei tunneta. 
Skitsofreniaa pidetään sairautena, jossa normaalisti toimivien aivojen toiminta 
häiriintyy. Psykoottisten oireiden ohella kognitiiviset häiriöt ovat skitsofrenian 
keskeisiä oireita. Potilailla havaitaan muistin, tarkkaavaisuuden ja 
toiminnanohjauksen häiriöitä, jotka liittyvät myös sairaudesta aiheutuviin 
psykososiaalisiin ongelmiin. Myös joillakin skitsofreniapotilaiden terveillä 
perheenjäsenillä havaitaan häiriöitä kognitiivisissa toiminnoissa, jotka kuitenkin 
ovat potilaiden häiriöitä lievempiä. Kognitiivisen toiminnan häiriöitä pidetäänkin 
skitsofrenian ns. endofenotyyppeinä, jotka ovat merkki mahdollisesta 
geneettisestä alttiudesta sairaudelle sen puhkeamisesta riippumatta.  
Tämä väitöstutkimus on osa laajempaa vakavien mielenterveyshäiriöiden 
geneettistä epidemiologiaa selvittävää tutkimusta, jota varten kerättiin edustava 
väestötasoinen perheaineisto skitsofreniaa sairastavista perheenjäsenistä sekä 
heidän terveistä vanhemmistaan ja sisaruksistaan. Yhteensä 975 henkilölle tehtiin 
diagnostinen haastattelu ja neuropsykologinen tutkimus. Väitöstutkimuksen 
tarkoituksena oli arvioida kognitiivisten häiriöiden periytyvyyttä sekä sitä 
vaikuttaako skitsofreniaa sairastavien perheenjäsenten määrä toisaalta 
perheenjäsenillä ja toisaalta sairastuneilla havaittujen kognitiivisten häiriöiden 
vaikeusasteeseen. Lisäksi tutkittiin sairastumisiän ja eräiden muiden kliinisten 
muuttujien vaikutusta kognitiivisiin häiriöihin sekä sairaiden perheenjäsenten 
määrän osuutta tähän. Ne neuropsykologiset muuttujat, joiden periytyvyydelle 
saatiin tukea, sisällytettiin koko genomin kattavaan geneettiseen 
kytkentäanalyysiin. Tarkoituksena oli tutkia tuottavatko sairauteen liittyvät 
jatkuvaluonteiset piirremuuttujat parempia kytkentätuloksia kuin aikaisempiin 
tutkimuksiin sisällytetty dikotominen diagnoosimuuttuja. Jatkossa tehtäviä 
geneettisiä tutkimuksia varten tehtiin vähintään kaksi skitsofreniaa sairastavaa 
potilasta ja heidän terveitä perheenjäseniään sisältävien perheiden 
klusterianalyysi, jonka tarkoituksena oli etsiä neuropsykologisissa testeissä 
samansuuntaisesti suoriutuvia perheitä.  
6Kognitiivisten häiriöiden periytyvyydelle skitsofreniaa sairastavissa perheissä 
saatiin tukea. Erityisesti työmuistihäiriöiden perinnöllinen osuus oli suuri, ja niitä 
näytti vastaavan rajattu määrä geenilokuksia. Verbaalisen muistin suhteen 
periytyvyys oli tässä tutkimuksessa epäselvempi. Perheen sairastuneiden määrä 
liittyi erityisesti visuaalisen työmuistin häiriöön. Varhaisempi sairastumisikä 
liittyi erityisesti verbaalisen muistin häiriöihin. Geneettisessä kytkentäanalyysissä 
työmuistimuuttuja antoi kiinnostavan kytkentätuloksen kromosomiin 2q. Useat 
verbaalisen muistin toiminnot näyttivät kytkeytyvän merkitsevästi kromosomi 
4q:n lokuksiin. Klusterianalyysi tunnisti perheistä kolme ryhmää, joissa 
perheenjäsenet sairaudesta riippumatta menestyivät keskenään samankaltaisesti 
neuropsykologisissa tehtävissä. Ryhmät nimettiin hyvin menestyvien, huonosti 
menestyvien ja niiden väliin sijoittuvien perheiden klustereiksi.  
Tutkimuksen tulosten perusteella perinnölliset tekijät selittivät merkittävän osan 
skitsofrenia-alttiuteen liittyvistä kognitiivisista häiriöistä. Neuropsykologisista 
testeistä saadut jatkuvaluonteiset muuttujat tuottivat merkitseviä tuloksia 
geneettisessä kytkentäanalyysissä. Kognitiivisen toiminnan suhteen 
samankaltaisten perheiden tunnistaminen voi hyödyttää jatkotutkimuksia 
sairauden monitekijäisen taustan selvittämisessä.  
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1    INTRODUCTION 
The present thesis is an exploration on cognitive impairments in patients suffering 
from schizophrenia, and in their unaffected first-degree relatives. The framework 
is in psychiatric genetics, a methodology that is used to understand why a mental 
disorder occurs in some families but not in others. In the present thesis, the 
psychiatric genetic framework is used in studying familiality and genetics of 
cognitive deficits in schizophrenia. Family is the basic unit of analysis in 
psychiatric genetics, following from the axiom that families influence the mental 
health of their members (Faraone et al 1999b). Furthermore, "genes do not act in 
isolation from other genes or from a person´s psychologic or physical 
environment. Think of genes as actors and the environment as their stage. 
Together they tell the story of human development. As psychiatric geneticists 
watch the play of psychopathology, they seek to identify the actors and learn how 
their behavior changes with the surrounding scene" (Faraone et al 1999b, p. 4).  
Schizophrenia is a devastating psychotic illness characterized by positive 
symptoms (delusions, hallucinations, and disordered thought), negative 
symptoms (withdrawal, avolition, apathy), and cognitive impairments such as 
attention and memory deficits. Schizophrenia tends to run in families. It has an 
indisputable genetic basis, although there is still absence of definitive genes, and 
the pathogenic molecular mechanisms remain unknown. As schizophrenia, like 
most mental disorders, shows complex inheritance, the transmission of the 
disorder most likely implies several genes and environmental factors that transmit 
the predisposition to the illness but not necessarily its expression.  
In many family studies, impaired performance in neuropsychological tests has 
been observed in both schizophrenia patients and their relatives, suggesting that 
these impairments may be biological markers indicating illness vulnerability. 
Consequently, many studies have concluded that these impairments may turn out 
to be valid endophenotypes - biological traits that confer vulnerability to the 
development of a disorder - to be included in genetic studies. However, only a 
few previous studies have actually used them in genetic analyses. Here, the 
heritability of certain cognitive traits was estimated, the association of familial 
loading and age of onset on cognitive traits was studied, and finally, the cognitive 
test variables were used as endophenotypes in a genomewide linkage study. For 
future genetic studies, a cluster analysis was conducted in order to identify such 
families in which both schizophrenia patients and their unaffected relatives 
performed convergently in neuropsychological tests. 
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2    REVIEW OF THE LITERATURE 
2.1 SCHIZOPHRENIC DISORDERS
Schizophrenic psychoses include schizophrenia, schizophreniform disorder, and 
schizoaffective disorder. In addition, schizoid personality disorder and 
schizotypal personality disorder are included in the so called schizophrenia 
spectrum disorders.  
2.1.1 Schizophrenia 
Schizophrenia is a severe psychiatric disorder with complex and multifactorial 
etiology. The prevalence of schizophrenia is about 1% worldwide. The onset of 
the disorder occurs usually at a young age, but it may appear at any age. The risk 
of illness is similar in females and males, but men tend to have an earlier onset 
than females, and the illness is often more severe in males. No single sign or 
symptom defines schizophrenia. The clinical picture is thus heterogeneous and 
expressed in several subtypes of the disorder (Andreasen 2000).  
Patients with schizophrenia have psychotic symptoms by definition, and continue 
to demonstrate ongoing and often profound mental status changes even in 
remission. The disease includes a severe disruption of personality and cognitive 
capacity, along with psychotic positive and psychotic negative symptoms (Fuller 
et al 2003). The positive symptoms are presence of such phenomena that should 
not be present in a normal individual. Typical positive symptoms are delusions 
and hallucinations, and disorganized thought and behavior. Negative symptoms 
are diminution or loss of functions or aspects of life that should be present in a 
normal individual. Typically, negative symptoms include withdrawal from social 
relationships, avolition, apathy and unattentivity. According to the Diagnostic and 
Statistical Manual of Mental Disorders, fourth version (DSM-IV) (American 
Psychiatric Association 1994), some signs of the disturbance must persist for a 
continuous period of at least six months, during which at least two of the 
following symptoms persist at least one month: delusions, hallucinations, 
disorganized speech, grossly disorganized or catatonic behavior, or negative 
symptoms. Table 1 shows the DSM-IV diagnostic criteria of schizophrenia.  
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Table 1. Diagnostic criteria for schizophrenia (DSM-IV, American Psychiatric 
Association 1994)
A. Characteristic symptoms: Two or more of the following, each present for a significant 
portion of time during a 1-month period (or less if successfully treated): 
1. Delusions 
2. Hallucinations 
3. Disorganized speech 
4. Grossly disorganized or catatonic behaviour 
5. Negative symptoms 
Only one Criterion A symptom is required if delusions are bizarre or hallucinations 
consist of a voice keeping up a running commentary on the person’s behaviour or 
thoughts, or two or more voices are conversing with each other. 
B. Social/occupational dysfunction: for a significant portion of the time since the onset of 
the disturbance, one or more major areas of functioning such as work, interpersonal 
relations, or self-care are markedly below the level achieved prior to the onset (or, when 
the onset is in childhood or adolescence, failure to achieve the expected level). 
C. Duration: Continuous signs of the disturbance persist for at least 6 months, of which at 
least one month should be of symptoms that meet Criterion A. The 6 months may include 
periods of prodromal and residual symptoms. 
D. Schizoaffective and mood disorder exclusion: Schizoaffective disorder and mood 
disorder with psychotic features have been ruled out because either no major depressive, 
manic, or mixed episodes have occurred concurrently with the active-phase symptoms, or 
if mood episodes have occurred during active-phase symptoms, their total duration has 
been brief relative to the active and residual periods. 
E. Substance/general medical condition exclusion: The disturbance is not due to the direct 
physiological effects of a substance or a general medical condition. 
F. Relationship to a pervasive developmental disorder: if there is a history of autistic 
disorder or another pervasive developmental disorder, the additional diagnosis of 
schizophrenia is made only if prominent delusions or hallucinations are also present for at 
least a month (or less if successfully treated). 
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Schizophrenia involves dysfunction in one or more major areas of functioning 
(e.g. interpersonal relations, work or education, or self-care). Educational 
progress is frequently disrupted, and the individual may be unable to finish 
school. Many individuals can not hold a job, and become easily unemployed, or 
employed at a lower level than their parents. The interpersonal relationships tend 
to remain few, and marriage occurs only in 30-40 % cases. The dysfunction 
persists for a substantial period of the disorder and does not appear to be a direct 
cause of any single feature (American Psychiatric Association 1994). Probably no 
other chronic illness similarly debilitates functioning as schizophrenia (Schultz 
and Andreasen 1999). Moreover, schizophrenia is associated with markedly 
increased age-adjusted mortality (Brown 1997). 
Prodromal symptoms often precede the active phase of the disorder, and residual 
symptoms follow the acute phase of the disorder (Häfner and an der Heiden 
2003). These symptoms may be milder forms of the psychotic symptoms, such as 
peculiar (but not bizarre) behavior, mumbling to oneself, or up to severe negative 
features, such as withdrawal from social contacts, loss of interest in previously 
pleasant activities, or spending most of the time in bed (American Psychiatric 
Association 1994). 
The first-degree relatives of patients with schizophrenia have a risk for the 
disorder about 10 times greater than that of general population. The risk for 
schizophreniform disorder or schizoaffective disorder, as well as schizoid and 
schizotypal personality disorder may also be increased in these subjects. On the 
other hand, risk of schizophrenia is increased in relatives of individuals with 
schizophreniform disorder or schizoaffective disorder (American Psychiatric 
Association 1994). 
2.1.2 Schizophreniform disorder  
Schizophreniform disorder is essentially identical to schizophrenia, except that 
the total duration of the illness (including prodromal, active, and residual phases) 
is at least one month but less than six months. Furthermore, the diagnosis of 
schizophreniform disorder does not require the impairment in social and 
occupational functioning that is one of the criteria in schizophrenia. This 
diagnosis is "provisional" in the sense that if the symptoms persist beyond six 
months, the diagnosis would be changed to schizophrenia (American Psychiatric 
Association 1994). 
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2.1.3 Schizoaffective disorder 
Schizoaffective disorder comprises both the full criteria of the active phase of 
schizophrenia and a major depressive episode lasting at least two weeks, or a 
manic or mixed episode lasting for at least one week. During the same period of 
illness, there must be an at least two weeks period of delusions and hallucinations 
without any prominent mood symptoms. The mood symptoms have to be present 
for a substantial portion of the entire period of illness, including the active and 
residual symptoms.  The total duration of the psychotic symptoms must be at 
least one month (American Psychiatric Association 1994). 
2.1.3 Schizoid and schizotypal personality disorder 
Schizoid personality disorder is characterized by detachment from social 
relationships, and a restricted range of emotions in interpersonal settings. It does 
not occur exclusively during the course of schizophrenia or another psychotic 
disorder. The essential feature of schizotypal personality disorder is a pervasive 
pattern of social and interpersonal deficits. This disorder involves cognitive or 
perceptual distortions, and eccentricities of behavior, thinking and 
communication. However, overt psychosis is absent (American Psychiatric 
Association 1994).  
2.2 COGNITIVE IMPAIRMENT AND SYMPTOMS IN SCHIZOPHRENIA
Cognitive impairments are one type of core symptoms in schizophrenia. The 
schizophrenia patients show deficits in attention, memory, and executive 
functions. The severity of cognitive dysfunction associates specifically with 
negative and to a lesser extent with disorganized symptoms, but usually not with 
the presence of delusions and hallucinations (Addington et al 1991; O'Leary et al 
2000; Rund et al 2004). Furthermore, improvement in symptom ratings has not 
been observed to associate with improved cognitive test performance (Hughes et 
al 2003). Negative symptoms associate with poor performance in verbal learning 
and memory, impaired conceptual thinking, object naming, visual and verbal 
long-term memory, and with verbal fluency (O'Leary et al 2000). Disorganized 
symptoms associate particularly with poor concentration and immediate recall of 
e.g. word lists (O'Leary et al 2000).  
Dysfunctions are related to several aspects of symptomatology and may prevent 
patients from attaining an optimal adaptation in their everyday life (Green 1996). 
Impairments in executive processes, including planning, problem solving and 
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enterprising, play a relevant role in restricting patients ability to retain, acquire, or 
relearn skills that are needed for psychosocial functioning (Keefe 1995). 
Generally, impaired cognition has been more closely than the clinical symptoms 
linked to community outcome, social problem solving and social skill acquisition 
(Green et al 2000). Furthermore, the psychosocial and other functional 
consequences of the disorder seem to be most clearly related to impairments in 
verbal memory functions (Green 1996).  
2.3 COGNITIVE DYSFUNCTIONS IN SCHIZOPHRENIA
An important component of schizophrenia involves compromized performance in 
most of the cognitive domains: working memory, executive function, verbal 
declarative memory, and attention. Although not all schizophrenia patients show 
impaired cognitive functioning, often a generalized deficit is observed. However, 
no specific “neurocognitive profile” exists for schizophrenia (Mohamed et al 
1999; Bilder et al 2000).  
Attenuated impairment is present already before the illness onset. Many subjects 
with prodromal symptoms show cognitive deficits, particularly in attention 
(Cornblatt and Malhotra 2001; Klosterkotter et al 2001), and although there is not 
one specific deficit that predicts the onset of the disorder, some dysfunction in 
cognition often precedes it (Cornblatt et al 1999). Usually schizophrenia 
symptoms break out together with a marked reduction in several critical cognitive 
domains (Riley et al 2000). The impairments do not directly associate with age, 
severity of symptoms, length of the illness, or medication (Aleman et al 1999), 
and they do not progress but remain stable (Heaton et al 2001; Hijman et al 2003; 
Kurtz 2005), showing generally no more worsening than what ageing normally 
brings along (Hyde et al 1994). Executive functions, however, may show a more 
accelerated decline (Fucetola et al 2000).  
Whether certain cognitive impairments are specific for schizophrenia has 
remained unresolved (Mohamed et al 1999). In their meta-analysis, Heinrichs 
and Zakzanis (1998) reported that individuals with schizophrenia score 
between one-half to one-and-a-half standard deviations below the control 
mean in a wide variety of neuropsychological domains including attention, 
memory, intelligence, motor speed, spatial ability, executive functioning and 
verbal fluency, thus showing a generalized deficit. Some patients do not show 
impairments compared with controls, but it may be that also their cognitive 
functioning has deteriorated from the premorbid level (Kremen at al 2000; 
Keefe et al 2005).    
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2.3.1 Attention 
Attention refers to processes of how an individual becomes receptive for external 
or internal stimuli (Lezak et al 2004). The critical attributes of attention are focus, 
selectivity, exclusiveness, and vigilance. To select from the stream of stimuli and 
to sustain attention are fundamental for all cognitive functioning.  
Since the early days when schizophrenia was first described, deficits in attention 
have been noted among the core cognitive impairments of this disorder. Individuals 
suffering from schizophrenia display a broad array of attention impairments, 
irrespectively of their clinical state (Cornblatt and Keilp 1994; Cornblatt et al 
1999). However, these impairments do not deteriorate as the illness progresses, 
suggesting that they are resulting from an early brain insult (Cornblatt et al 1997). It 
is also unlikely that they explain but a small portion of the variance in other 
cognitive functions (Kenny and Meltzer 1991). Impairments in attention seem not 
to be due to medication, as they can be observed in unmedicated patients as well. In 
fact, in some patients with antipsychotic medication, attention may improve (Serper 
et al 1994), and even conventional neuroleptics, often considered to impair 
cognition, may also enhance attention (Mishara and Goldberg 2004). Impaired 
attention is likely to be a marker of biological liability to schizophrenia, as 
individuals with vulnerability to this disorder display deficits in attention long 
before the appearance of other symptoms. These deficits also function as good 
predictors of the later developing schizophrenia in children with high risk of the 
disorder (Erlenmeyer-Kimling et al 2000). 
2.3.2 Declarative memory  
Memory is the outcome of learning. The human memory is a complex system by 
which an individual registers, stores, retains, and retrieves information (Lezak et 
al 2004). The memory system is usually divided into short-term and long-term 
memories. Short-term memory can be divided into immediate and working 
memory, and long-term memory includes declarative (explicit) memory and 
nondeclarative (implicit) memory.  
There exists a consensus about global memory impairment in schizophrenia 
patients (Aleman et al 1999). In particular, impairments are detected in episodic 
memory, a subsystem in declarative memory, even to an extent of being the 
relatively greatest against the global cognitive dysfunction (Saykin et al 1991; 
Saykin et al 1994; Heinrichs and Zakzanis 1998; Mohamed et al 1999; Cirillo 
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and Seidman 2003). People with schizophrenia learn less than healthy 
individuals, e.g. when presented word lists. They do not use effective learning 
strategies, such as semantic clustering, not even when told to cluster the 
information. However, they tend to show intact recognition memory (Conklin et 
al 2002), thus suggesting more impairment in explicit compared with implicit 
memory (Sponheim et al 2004).  
Cirillo and Seidman (2003) reviewed the literature from years 1999 to 2001 
inclusive on the dysfunction in verbal declarative memory in schizophrenia. 
They concluded that verbal declarative memory seems to be among the most 
impaired neuropsychological functions in the patients with this disorder. 
Based on the reviewed literature, particularly the encoding stage seemed to 
account for the deficits. In a meta-analysis on the relative sensitivity and 
reliability of different measures and findings across the studies on 
neurobiology and brain function in schizophrenia, the most powerful and 
robust case-control differences pertain to cognitive and psychophysiological 
aspects of brain function rather than to neuroanatomical or neurochemical 
findings (Heinrichs 2004). In the ranking list of the best measures, general 
verbal memory impairment received the second highest effect sizes of all 
measures (Heinrichs 2004).  
2.3.3 Working memory 
Working memory refers to a multicomponent cognitive system that is serving to 
hold a limited amount of information "online" for a short period of time, and to 
simultaneously manipulate the information so that it is available for further 
cognitive processing, or to guide response selection, relevant for a specific 
context (Baddeley 1992). The subsystems of working memory comprise the 
central executive with two short-term slave stores: the visuospatial scratch-pad 
for visual information, and the articulatory loop for phonological information 
(Baddeley 1996). The central executive is responsible for the coordination of the 
processing of material in the slave systems and has access to long-term memory.   
It has been argued that impaired working memory is the core cognitive deficit in 
schizophrenia, associating with the clinical picture and the functional 
consequences of the disorder (Goldman-Rakic and Selemon 1997; Goldman-
Rakic 1999). Both verbal and nonverbal working memory are dysfunctional in 
schizophrenia (Park and Holzman 1992; Conklin et al 2000; Okada 2002). It has 
even been suggested that core symptoms of schizophrenia may emerge as a result 
from a breakdown in the working memory processes (Goldman-Rakic 1999). 
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Albeit a discrete cognitive function, working memory can also be considered a 
capacity for a wide range of complex cognitive functions, such as comprehension, 
learning, reasoning, and planning. Working memory plays an important role during 
the encoding process. Seidman et al (1998) found that during a verbal learning task 
in which the words can be semantically clustered, the differences between 
schizophrenia patients and healthy controls were eliminated when the results were 
controlled for scores in a working memory task. It is likely that abnormalities in 
working and strategic memory contribute substantially to the verbal encoding 
deficit in schizophrenia, as well as to other cognitive functions.  
2.3.4 Executive function 
Executive functions involve the use of information rather than the 
fundamental processing of information, and refer to the processes by which an 
individual realizes purposeful behavior (Lezak et al 2004). Executive 
functioning includes the ability to solve problems, formulate strategies, 
evaluate, select and discard useless strategies. It also refers to a flexible 
ability to alternate between competing strategies and adaptively shift to new 
strategies.  
Schizophrenia patients have shown impairments in many areas of executive 
functioning. They have difficulties in abstraction, set shifting and response to 
feedback (Gold et al 1997). The deficits in executive functions aggravate the 
schizophrenia patients´ capacity to deal with everyday activities, and to adapt 
to novel situations. Usually the patients perform poorly in such tests 
measuring executive functioning as Wisconsin Card Sorting Test, the Trail 
Making Test, the Stroop test, or the Verbal fluency test (Elliott et al 1995; 
Chan et al 2004).  
2.4 SPECTRUM DISORDERS AND COGNITIVE IMPAIRMENTS 
Individuals with schizophreniform disorder or schizoaffective disorder have 
cognitive deficits in the same domains and comparable with those in 
schizophrenia patients (Cadenhead et al 1999; Townsend et al 2001; Goldstein et 
al 2005), being present in the first episode of these disorders (Addington et al 
2003). Furthermore, in a recent report, Matsui et al (2004) studied patients with 
schizotypal personality disorders and compared them with schizophrenia patients 
and controls. They found that patients with schizotypal personality disorder 
showed similar impairments in verbal memory and visuomotor ability than 
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patients with schizophrenia, while the latter scored lower than the former in tests 
assessing executive functioning. Differences between patients and the control 
group were consistent in all measures (Matsui et al 2004). In a twin study, 
Johnson et al (2003) found that schizotypal symptoms in co-twins with 
schizophrenia were associated with increased risk of impairment in attention, 
working memory, verbal memory, and executive functioning. This was not 
observed in twins without a schizophrenic co-twin, which suggested a genetic 
association between the cognitive impairment in schizophrenia and schizotypal 
personality disorder (Johnson et al 2003). 
2.5 SCHIZOPHRENIA AND BIPOLAR DISORDER – SIMILAR OR DIFFERENT 
COGNITIVE IMPAIRMENT?
Symptomatic patients with schizophrenia and bipolar disorder have been found to 
display similar degree of cognitive deficits, particularly in tasks of attention and 
problem solving (Zihl et al 1998). Similar results have also been obtained by Hoff 
et al (1990), who failed to differentiate between the deficits of schizophrenia and 
bipolar patients in acute psychosis, after controlling for age, sex, education, 
duration and severity of illness, and medical status.  
Both acute schizophrenia patients and acute manic patients have been found to 
show working memory deficits in a spatial task (McGrath et al 2001). However, 
in remission only schizophrenia patients were impaired, which suggests that this 
deficit may act as a trait marker on schizophrenia, but in mania it may be more 
state dependent (McGrath et al 2001). In another study (Rossi et al 2000), a group 
of euthymic bipolar patients were compared with schizophrenia patients and 
control subjects using Wisconsin Card Sorting Test (WCST) (Heaton 1981), 
which involves multiple cognitive processes, working memory and problem 
solving included. Bipolar patients performed better than patients with 
schizophrenia, but worse than controls even in remission (Rossi et al 2000). 
Dickerson et al (2001) found that schizophrenic and bipolar outpatients differed 
only in immediate verbal memory, when a comprehensive neuropsychological 
test battery was employed. The bipolar patients were as impaired as 
schizophrenia patients in overall social functioning, but not in social effectiveness 
or verbal social skills. The better social effectiveness in bipolar patients may be 
due to their less impaired declarative verbal memory, which is a good measure in 
assessing the functional consequences of psychosis (Green 1996). 
A recent study with severely ill chronic schizophrenia and bipolar patients found 
that the patient groups had similar neuropsychological impairments, which, 
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however, were more severe in the schizophrenia group (Seidman et al 2002a).  In 
this study, both patient groups had suffered from the disorders from about the 
same age and had the same number of hospitalizations, although on individual 
level schizophrenia patients scored worst on these dimensions. The differences in 
cognitive impairment between the patient groups were quantitative rather than 
qualitative, and the authors concluded that their results support the view of 
clinical continuum but not necessarily the etiological similarity of these 
dysfunctions (Seidman et al 2002a).  
Mojtabai et al (2000) detected a significantly worse neuropsychological test 
performance in schizophrenic first episode patients than in affective patients with 
psychotic symptoms. Subjects with schizophrenia expressed more generalized 
deficits and performed worse than bipolar patients, particularly in tests of 
attention, concentration and mental tracking. In a study comparing patients with 
schizophrenia and major affective disorder in their first episode of illness, a 
dysfunction in a broad range of functions was found among groups in patients 
with psychotic symptoms (Albus et al 1996). Frontal dysfunction, which is 
typical for chronic psychotic patients, was not so pronounced in the psychotic 
first episode patients.  Affective disorders without psychotic symptoms were not 
associated with cognitive dysfunction as compared with controls.  
In the study by Fleck et al (2001) acutely ill patients with bipolar disorder, 
schizophrenia, and healthy controls were compared using a test of sustained 
attention with degraded stimuli, and although no differences between the patient 
groups were found in sensitivity measures (i.e. hit/false alarm quotient), the 
schizophrenia patients showed a significantly longer hit reaction time than the 
bipolar patients. In all measures, patients performed worse than the healthy 
controls. The authors emphasize that information processing speed as one aspect 
of attentional capacities may be important in characterizing attentional 
dysfunction in major psychiatric disorders (Fleck et al 2001). Earlier, Brébion et 
al (1998) suggested that slowing of information processing may indeed be the 
factor that limits the effectivity of working memory in schizophrenia patients. A 
generalized slowing of information processing is commonly thought to be the 
source of many cognitive decrements (Salthouse 1996), and has recently been 
found to mediate test performance in bipolar patients, too (Kieseppä et al 2005). 
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2.6 PSYCHOPHARMACOLOGICAL TREATMENT AND COGNITION IN SCHIZOPHRENIA
The conventional antipsychotic medication has shown the best treatment responses 
on the positive symptoms of the illness, with much less impact on negative 
symptoms, mood symptoms, or cognitive deficits (Keefe et al 1999). However, the 
functional disability of schizophrenia is strongly associated with negative 
symptoms that correlate with the cognitive impairment but not with the positive 
symptoms. During recent years, the psychopharmacological research has focused 
on developing such new generation antipsychotic drugs that are targeted in the 
treatment of negative symptoms and cognition (Elvevåg and Goldberg 2000).  
It has still remained controversial whether the novel antipsychotic medication 
enhances cognition over the conventional treatment, and whether there are 
differences across the novel drug preparations (Freedman 2003). The 
conventional drugs may have heavier side-effects than the atypical drugs, 
requiring own treatment such as anticholinergics that show impairing effects on 
cognition, too (Davidson et al 1995).  In a meta-analysis, Keefe et al (1999) 
concluded that atypical neuroleptic treatment was more effective in producing 
cognitive improvement than the conventional treatment. Compared with placebo 
treatment, the novel drugs have been associated with enhanced performance in 
several cognitive tests, although with differential effect on different cognitive 
domains (Weickert et al 2003). 
However, also the conventional antipsychotic drugs may enhance cognition. In a 
recent meta-analysis "opening the closed book" on the effects of conventional 
neuroleptic treatment on cognition, Mishara and Goldberg (2004) found a modest 
to moderate enhancing effect on most cognitive domains, although motor 
function was adversely impacted. Interestingly, they did not find any significant 
relationship between improvement of symptoms and enhanced cognition, 
suggesting that both symptoms and cognition may improve, but they do not 
covary. In a study comparing neuropsychological test performance of 
unmedicated first-episode patients with their test scores after 1,5 years of 
treatment, no impairments or improvement was observed, irrespective of their 
decreased symptom ratings (Censits et al 1997). 
It is not clear, whether the beneficial effect on cognition of the atypical 
antipsychotics observed in some studies emerges from the absence of the side-
effects of the large doses of the typical (conventional) neuroleptics that require 
additional medication. Recently, Keefe et al (2004) published a comparison of 
olanzapine (atypical) and haloperidol (typical). They found that although 
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olanzapine was beneficial on cognitive functioning in first-episode psychosis, low 
doses of the typical drug showed almost similar effects.  
2.7 ETIOLOGY OF SCHIZOPHRENIA
2.7.1 The neurodevelopmental theory of schizophrenia 
A theory of schizophrenia as a complex illness should explain the etiology of the 
illness, the timing of the illness, and the heterogeneous character of the illness 
(Heinrichs 2001). The basic questions concerning the etiology of schizophrenia are: 
Does the neuropathology of schizophrenia stem from genetic influences, from the 
physical environment, or from both in some weighted combination? Regarding the 
onset, questions arise: What determines the timing of the illness, why the illness 
onset is so rare in childhood and so common in the third decade of life - what 
noxius combination of events causes the high incidence right at the time of young 
adulthood and physical maturity?  Family influences are regarded as important 
stresses and mediating forces in the life of patients with schizophrenia, but they are 
not regarded as causes of psychotic illness (Heinrichs 2001). 
Although neither Kraepelin nor Bleuler, the early theoreticians of schizophrenia, 
provided a comprehensive theory of schizophrenia, both noted that individuals 
suffering from this illness may have shown premorbid changes many years before 
the illness had actually emerged. Furthermore, Kraepelin was aware that early 
insults in brain development may have been implicated in schizophrenia. 
However, the modern forms of the neurodevelopmental theory were first 
presented year 1987 when Weinberger published his landmark paper on the issue 
(Weinberger 1987). In this paper, he suggested that a prenatal or perinatal event 
or lesion could disturb the normal sequence of brain development. This early 
disruption was thought to be clinically silent until after puberty, when 
maturational events lead to the emergence of the symptoms of schizophrenia. The 
static alterations in brain sturucture, the correlations with problems in early life 
adaptation, the findings of cytoarchitectural disorganization of cortex, and the 
absence of gliosis have been thought to be consistent with the possibility of a 
developmental anomaly (Weinberger 1995; Andreasen 1999). The profound 
behavioral and cognitive symptoms of the disease may ultimately be explained by 
neurodevelopmental disruptions and subsequent changes in complex aspects of 
brain function (Tamminga 1999). Thus there is an interaction between genetic 
and environmental factors during critical early periods of brain development that 
adversely impacts on adult mental health. 
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Converging data warrant the assumption that schizophrenia is a 
neurodevelopmental disorder, and individuals who manifest schizophrenia in 
adulthood, suffer from some form of subtle cerebral maldevelopment during the 
time of pregnancy or infancy (Lencz et al 2001; Lewis and Levitt 2002). 
Furthermore, schizophrenia has not been found to be associated with an increased 
frequency of Alzheimer´s disease or any other known neurodegenerative 
disorder, which gives support to the model of the neurodevelomental origin of 
schizophrenia (Harrison and Weinberger 2005).  
Recently, Sullivan et al (2003) published a meta-analysis on twin studies of 
schizophrenia. That analysis, based on 12 published studies, supported the view 
that schizophrenia is a complex disorder with substantial genetic effects, plus 
with a small but significant contribution of shared environmental effects. The 
point estimate of heritability was found to be 81% (95% confidence interval, 
73%-90%), while the shared environmental influences in liability was 11% (95% 
CI, 3%-19%). As the environments of twins are most similar in utero and 
immediately after birth, the common environmental effects on liability to 
schizophrenia most likely occur early in life. Along with consistent evidence of 
prenatal and perinatal insults such as pregnancy and obstetric complications for 
the risk of schizophrenia, the authors conclude their result further supporting the 
neurodevelopmental etiology of schizophrenia (Sullivan et al 2003).   
2.7.2 Environmental factors 
Several environmental risk factors may increase the risk of developing 
schizophrenia in persons with genetic susceptibility to the disorder. Maternal 
influenza during the second trimester of pregnancy (Mednick et al 1988), rubella 
(Brown et al 2001), malnutrition (Susser and Lin 1992), polio virus (Suvisaari et 
al 1999), as well as the effects of Rhesus incompatibility (Hollister et al 1996), 
are among the suggested prenatal risk factors, although results in any of these 
factors have remained controversial (Brown and Susser 2002). Perinatally, 
obstetric complications such as hypoxia, and low birthweight caused by 
intrauterine growth retardation, may increase the risk of schizophrenia (Hultman 
et al 1997; Cannon et al 2002b). It is not yet known whether the high occurrence 
of obstetric complications is a result of abnormal brain development that is 
reflecting genetic vulnerability to the disorder, or an additive environmental 
factor (Mueser and McGurk 2004).  
Socio-economic factors, such as poverty and lower social class have been found 
to be linked to high occurrence of schizophrenia. This may arise either from the 
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association between stressful environmental conditions and an increased risk, or 
from the decreasing effect of schizophrenia on social and occupational 
functioning (Häfner et al 1999). Urban births have been suggested as risk factors 
(Marcelis et al 1998; Haukka et al 2001), as well as winter births (Battle et al 
1999), although results are partly controversial (Davies et al 2003; Suvisaari et al 
2004). Severe instability of the childhood rearing environment, and deviant 
communication between parents, may be among he later risk factors for 
development of schizophrenia (Wahlberg et al 1997; Tienari et al 2004). 
2.7.3 Genetic factors  
Twin and adoption studies have shown that the genetic basis of schizophrenia is 
high, with heritability estimates up to 80% (Cannon et al 1998; Cardno et al 
1999; Sullivan et al 2003). In families, the genetic distance to a schizophrenic 
patient affects on the risk of the illness of a relative. Sharing 50% of the genes, 
parents of a patient have a 6 % risk, siblings a 9 % risk and children a 13% risk to 
be affected. The prevalence in an adopted offspring of schizophrenia mothers, 
reared by unaffected mothers, is the same as siblings reared by their affected 
mothers, indicating that the familiality of the disorder is not explained by the 
family environment (Gottesman and Shields 1982).  
A recent study by Tienari et al (2004) compared the effect of family rearing 
dimensions and functioning on developing schizophrenia spectrum disorders 
among adoptees of affected mother with those without this genetic risk. The study 
showed that only in the adoptees with the genetic risk the disordered family 
rearing increased risk to these disorders in a 21 years follow-up (Tienari et al 
2004). However, the concordance of schizophrenia among identical twins, 
sharing 100% of the genes, is less than 50%, which clearly shows the 
environmental importance and the lack of genetic determinism in schizophrenia. 
It has to be kept in mind that a disorder that clusters in families is not necessarily 
genetic (Gottesman and Shields 1982).  
Identification of the genes that function behind the high heritability of 
schizophrenia is essential for understanding the biological background of the 
disorder and its etiology. The identification of genes is most probably inevitable 
also for structuring the environmental and epigenetic factors involved in the 
process of developing the illness (Harrison and Weinberger 2005). Gottesman and 
Shields wrote year 1967 that one should not be satisfied with a polygenic theory of 
schizophrenia for too long, if other viable theories emerge (Gottesman and Shields 
1967). Congruently with the views of that time, it still seems evident that there is 
27
not one single gene that would determine the person to develop schizophrenia. 
Instead, it is likely that effects of multiple genes acting additively or 
multiplicatively provide the best model. According to this model, no particular 
constellation of genes will be characteristic in all ill individuals (Harrison and 
Weinberger 2005), and a set of genes that combine to produce schizophrenia in one 
family may not be the same as those that cause it in another family (Tsuang 2001).  
Several genome scans on schizophrenia have been conducted, and many of them 
have produced significant LOD scores on several chromosomal locations, but the 
discovery of genes predisposing to schizophrenia has thus far remained elusive 
(Lewis et al 2003). A successful search for the genes has partly been hindered by 
the diagnostic and symptomatic complexity of the disorder and on its diagnostic 
criteria that lean on a clinical rather than an etiological standpoint. Furthermore, 
schizophrenia is a common disorder, which results in common genetic liability 
variants, found with relatively high frequency in the general population. The 
genetic and environmental variables may all have a small effect that act in an 
additive fashion to produce a vulnerability to the disorder (Gottesman and 
Erlenmeyer-Kimling 2001). 
Although the search for the genes of the disorder has not thus far been very 
successful, recent progress in genetics in general and psychiatric genetics have 
given new optimism for this effort (O'Donovan et al 2003; Harrison and 
Weinberger 2005). It has been argued that "it is time to move away from solely 
statistical arguments to directly test the importance of specific loci and genes" 
(Harrison and Weinberger 2005, p. 44). Several reviews published during the last 
couple of years describe a list of genes, which might warrant the title of 
schizophrenia genes (O'Donovan et al 2003; Owen et al 2004) (Table 2). The 
evidence for these particular genes seems statistically and neurobiologically 
possible (Harrison and Owen 2003).  
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Table 2. Putative candidate genes of schizophrenia 
Gene       Chromosome Locus  Replication
________________________________________________________________ 
NRG1 (Neuregulin 1)     8p12-p21   Yes 
DISC1        1q42    Yes  
DTNBP1 (Dysbindin)     6p22    Yes 
G72         13q22-34   Yes 
DAAO (D-aminoacid oxidase)   12q24    No 
RGS4        1q21-22    Yes 
PRODH (Proline dehydrogenase)  22q11    Failed 
COMT (Cathecol-O-methyltransferase) 22q11    Yes 
________________________________________________________________ 
In Finnish study samples, several chromosomal regions have shown linkage with 
schizophrenia. These include 1q, 2q, 5q, and 7q (Hovatta et al 1999, Ekelund et al 
2000, Paunio et al 2001, Hennah et al 2003). The molecular genetic studies in 
Finland have included both dense maps in certain chromosomal regions and 
genomewide linkage studies. The linkage results originally received by Hovatta et 
al (1999) and Ekelund et al (2001) have been recently replicated in a large sample 
including the original one (Ekelund et al 2004). The region 1q42 of includes 
interesting candidate genes for schizophrenia, DISC1 and DISC2, which are 
disrupted by the breakpoint of a balanced (1;11)(q42;q14) translocation linked to 
schizophrenia, and have been associated with schizophrenia in Scottish studies, 
too (e.g. Millar et al 2000). Hennah et al (2003) found further evidence for the 
hypothesis that the DISC1 gene is involved in the etiology of schizophrenia, and 
implies a putative sex difference for the effect of the gene. In particular, DISC1, 
which has been found to express in proteins involved in neurodevelopment and 
neuronal migration, has shown interesting associations with cognitive functions 
(Hennah et al, submitted). 
2.7.4 Epigenetic effects 
Epigenetic mechanisms, defined as regulation of such genomic functions that are 
controlled by heritable but potentially reversible changes in the DNA that cause 
permanent change of function or form of a cell (Petronis 2004; Gottesman and 
Hanson 2005), have been suggested to have an impact on the complexity of both 
the clinical symptomatology and genetic epidemiology of schizophrenia. According 
to the epigenetic approach, the actual phenotype of an individual depends on the 
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interaction of many genes and the environmental influences on them, plus 
stochastic events, based on random variation (Gottesman and Hanson 2005).  
Although there is no direct experimental evidence that epigenetic factors do 
actually impact the development of schizophrenia, it can be imagined that 
schizophrenia results from a chain of unfavorable epigenetic events that begin with 
a primary epigenetic defect, so called epimutation. These events may then cause no 
clinical problems during decades, although they may result in a variety of minor 
cytoarchitectural changes in the brain, which in turn are observed as subtle 
neuropsychological or neurological aberrations that can be observed in some 
children who later develop schizophrenia (Erlenmeyer-Kimling et al 2000; Petronis 
2004). However, only some individuals with these epimutations will outrun the 
"threshold" and get the full-blown illness. Epigenetics is one mechanism that could 
explain why the genetically identical twins do not show concordance for example 
to schizophrenia (Gould and Manji 2004; Petronis 2004).  
2.8 STRUCTURAL AND FUNCTIONAL BRAIN ABNORMALITIES IN SCHIZOPHRENIA
There is no doubt that schizophrenia is a brain disease (Harrison 1999).  Along 
with ventricular enlargement (Gaser et al 2004), subtle but significant reductions 
in brain volume and weight have been observed (Lawrie and Abukmeil 1998; 
Harrison et al 2003). Abnormalities in gray and white matter (Cannon et al 
2002a; Job et al 2002), hippocampal volume and shape (Nelson et al 1998; 
Harrison 2004; van Erp et al 2004), cortical thickness and folding (Kuperberg et 
al 2003; Harris et al 2004), gyrification (White et al 2003) and volume, 
particularly in the prefrontal cortical areas (Wiegand et al 2004), have been 
detected in prodromal, drug-naïve, first-episode patients, and chronic patients 
(Seidman et al 2002a; Faraone et al 2003; Salgado-Pineda et al 2003).   
Functional MRI studies have indicated that in schizophrenia, there is aberrant 
activity and connectivity in the components of distributed circuits involving the 
prefrontal cortex (Ragland et al 2004), hippocampus (Jessen et al 2003) and 
certain subcortical structures (Eyler Zorrilla et al 2003). Significant 
hypoactivation has been found particularly in the right hemisphere, in the 
dorsolateral frontal and temporal regions and in the inferior parietal, and 
subcortically in the thalamus (Salgado-Pineda et al 2004).   
However, thus far the neuropathological findings do not warrant to be considered 
diagnostically useful, or to explain the cause of the disorder (Harrison and 
Weinberger 2005). The disorder is characterized by small to moderate case-
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control differences across measures of cerebral structure and function, whereas 
the differences in cognition and psychophysiological measures, such as verbal 
memory, or eye-tracking and event-related potentials, may be relatively large 
(Heinrichs 2004).  
2.9 COGNITIVE DYSFUNCTIONS IN RELATIVES OF PATIENTS WITH SCHIZOPHRENIA
Studies on the cognitive functioning of the first-degree relatives of the 
schizophrenia patients have suggested that the dysfunction may be familial or 
genetic. In several studies, cognitive deficits in relatives of schizophrenia patients 
have been found to parallel those observed in the patients, although to a milder 
degree (Cannon et al 1994; Faraone et al 1995; Lyons et al 1995; Toomey et al 
1998; Faraone et al 1999a; Seidman et al 1999; Gilvarry et al 2000; Seidman et al 
2002b; Toulopoulou et al 2003). Twin studies have shown that the deficits 
correlate more strongly in discordant monozygotic than in discordant dizygotic 
twins (Goldberg et al 1990; Cannon et al 2000b). Dysfunction in cognition has 
also been observed to appear in subjects at high risk for schizophrenia, and 
particularly deficits in attention during childhood may predict schizophrenia in 
subjects with at least one affected parent (Erlenmeyer-Kimling et al 2000). 
Relative risk of the impairment seems to be particularly elevated for verbal 
memory, psychomotor speed and working memory (Egan et al 2001a).  A recent 
meta-analysis (Sitskoorn et al 2004) examined neuropsychological test data on 37 
studies, comprising 1639 relatives of schizophrenia patients and 1380 comparison 
subjects. Reporting the results as Cohen´s effect sizes (Cohen 1988), it was 
concluded that the relatives of patients with schizophrenia show less cognitive 
efficiency than healthy controls on several cognitive measures. However, no 
single test did adequately discriminate relatives from controls, albeit the best 
effect sizes were found in verbal recall measures (d=0.54, 95% CI 0.43-0.66). 
This moderate effect size implies that substantial numbers of relatives perform 
within a normal range in the neuropsychological tests, and that cognitive 
deficiency can not be considered to characterize each relative of a patient with 
this disorder (Sitskoorn et al 2004). Still, on some measures the test performance 
of the relatives is more than half a standard deviation lower than that of healthy 
controls. Appels et al (2003) compared unaffected parent couples of 
schizophrenia patients with healthy control couples and found that the former 
performed significantly worse than the controls in measures that previously had 
been found to be most impaired in schizophrenia patients (Heinrichs and 
Zakzanis 1998).  These measures included global verbal memory, motor skills, 
verbal attention and executive function (Appels et al 2003). This result is of 
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particular interest as the parents represent an age group (mean age 53.6 years) 
that already had passed the age at risk for schizophrenia.  
Verbal and visuospatial memory deficits and attentional dysfunction have 
consistently been found in patients and their relatives (Faraone et al 1995; 
Park et al 1995; Faraone et al 1999a; Conklin et al 2000; Egan et al 2000). In 
a family study (Almasy et al 2000), marked heritabilities were observed for 
attention, spatial memory, spatial processing, and verbal reasoning. Impaired 
visuospatial working memory and recall errors in a verbal memory task have 
recently been linked to genetic loading for schizophrenia in a relatively large 
sample of twins in Finland (Cannon et al 2000b). Genetic influences in 
schizophrenia were associated with reduced semantic encoding of verbal 
information, but non-genetic influences further compromised the episodic 
memory system in patients with the full-blown schizophrenia phenotype. In 
another study on Finnish twins, van Erp et al (submitted) found that episodic 
memory processes were more impaired than non-episodic memory processes in 
patients with schizophrenia. Based on MRI-scans, these disturbances suggested 
hippocampal pathology and supported previous results in which reduced 
hippocampal volumes have been associated with genetic liability for 
schizophrenia (Lawrie et al 2001; Seidman et al 2002a).  
In high-risk children of schizophrenic parents who later develop schizophrenia, 
several impairments in cognition have been observed prior to the illness onset. In 
addition to dysfunctional motor development (Jones et al 1994; Cannon et al 
1999), these children tend to perform poorly in cognitive tests and gain lower IQ 
than high-risk children who do not get affected (Kremen et al 1998; Davidson et 
al 1999; Cannon et al 2000a; for a review see Niemi et al 2003). 
2.10 STRUCTURAL AND FUNCTIONAL BRAIN ABNORMALITIES OF RELATIVES OF 
SCHIZOPHRENIA PATIENTS
Similar reductions in frontal and temporal regions of the brain as in schizophrenia 
patients, but in attenuated form, have been revealed in relatives of schizophrenia 
patients (Lawrie et al 2001; Cannon et al 2002a), thus suggesting shared genetic 
liability. Regional volume reductions related to a genetic liability to 
schizophrenia include those found in the thalamus and temporal and frontal lobes 
(McIntosh et al 2004). Some evidence also suggests that some volume reductions 
found in the medial temporal lobe might be related either to environmental 
factors (e.g., obstetric complications) or to the actual manifestation of the illness 
(McNeil et al 2000; Lawrie et al 2001). Schulze et al (2003) failed to find 
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evidence that hippocampal volume loss would be associated with familial liability 
to schizophrenia. Instead, they found association between hippocampal volume 
loss and obstetric complications. In a study by McIntosh et al (2004), reduced 
anterior thalamic gray matter was found in relatives of schizophrenia and bipolar 
patients, which suggests liability to psychosis in general.  
Following from the observation that relatives of schizophrenia patients show 
deficits in attention, declarative memory, and certain electrophysiological 
measures such as sensorimotor gating and eye tracking, there may also be 
functional abnormalities in the functioning of prefrontal cortex and associated 
regions, including thalamus and hippocampus.  Although only a few studies have 
studied this, the results have shown abnormalities expressed as exaggerated 
functioning in the prefrontal cortex (Callicott et al 2003), or reductions in this 
functioning (Keshavan et al 2002). A recent study (Thermenos et al 2004) 
supported the view that functioning of the thalamic nuclei was increased 
compared with control subjects during a working memory task. The exaggerated 
activation may reflect the reduced thalamic volume that has been observed in 
relatives with schizophrenia patients (Seidman et al 1999).    
2.11 ENDOPHENOTYPES IN THE GENE SEARCH
2.11.1 The concept of endophenotype 
Although it has become relatively simple to localize and characterize genes for 
monogenic disorders, the situation is quite different in complex psychiatric 
disorders, which are influenced by multiple genes and their interaction, and for 
which there is no laboratory test available for diagnosis. An alternative way to 
find susceptibility genes for complex disorders may be using traitlike variables 
associated with the disorder as phenotypes in genetic studies (Faraone et al 1995; 
Freedman et al 1999; Egan and Goldberg 2003). For this reason, there has arisen 
interest in examining traits that directly index the underlying pathology or 
liability to the disorders, and that can be observed both in patients and their 
relatives. Because some relatives of patients carry genes for the illness although 
the illness is not expressing in them, the abnormal brain functioning that is often 
observed in them is not secondary to the illness or to the effects of its treatment. 
Rather, it can be attributed to the effect that the illness genes have on the brain 
even in the absence of the full-blown illness (Faraone et al 1999b). 
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This effort to identify intermediate phenotypes, or endophenotypes, is driven by 
the idea that they involve the same biological pathways as the disorder but are 
closer to the relevant gene action than the categorical diagnoses, thus adding 
power to genetic studies. The endophenotypes are assumed to have a simpler 
genetic architecture than the disorder that they correspond (Freedman et al 1999), 
although many of them may be complex, too (Egan et al 2003). 
The endophenotype refers to an internal phenotype that can be discovered by 
measurements, but is not seen without an “aided eye” (Gottesman and Shields 
1982; Gottesman and Gould 2003). It is the intermediate factor between the 
phenotype and genotype. The endophenotypes may be any neurobiological 
measures related to the underlying molecular genetics of the illness, including 
biochemical, endocrinological, neurophysiological, neuroanatomical, or 
neuropsychological markers.  
However, the endophenotypes should fulfill several criteria before they can be 
considered valuable: 1) the endophenotype is associated with illness in the 
population, 2) the endophenotype is significantly heritable, 3) the endophenotype 
is present in individuals with and without an active phase of the illness, 4) in 
families with the illness, also the unaffected relatives have the same 
endophenotypic trait, and 5) the endophenotype that is present in the affecteds, is 
more prevalent in the unaffecteds in the family than in general population 
(Gottesman and Gould 2003). The measurements that are used to evaluate the 
endophenotypic traits, e.g. neuropsychological tests, may not have a sensitivity or 
specificity of 100% for the disorder phenotype, i.e. the diagnosis – if it was, no 
additional gain in power would be received (Egan et al 2003). 
In schizophrenia, several types of endophenotypes that fill the above listed 
criteria, have been suggested. These include eye-tracking abnormalities 
(Kathmann et al 2003), certain electrophysiological markers, such as event-
related potentials measuring the P300 amplitude abnormalities (Blackwood et al 
1991; Winterer et al 2003), neurochemical variations, for example 
pharmacological treatment response parameters (Garver et al 2000), or scores 
from negative and positive symptom scales (Wilcox et al 2002). Recently, 
neuroimaging phenotypes have produced interesting results (e.g. Cannon et al 
2002a) about the genetic effects of schizophrenia on brain morphometry as 
measured with MRI, or from fMRI studies of the effect of COMT genotype on 
prefrontal functioning (Egan et al 2001b; Marcelis et al 2003).   
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2.11.2 Neuropsychological endophenotypes 
The search for the schizophrenia endophenotypes "to inform genetic studies of 
psychiatric disorders is never as productive and exciting as in neuropsychological 
studies" (Egan and Goldberg 2003, p. 163). This is because the cognitive deficits 
observed in schizophrenia are, unlike those in other psychiatric disorders, trait-
like core features of this illness that are closely related to clinical and functional 
outcome. Furthermore, the neurobiology of some of the cognitive functions, such 
as working memory and verbal memory, are increasingly well understood.   
It has been suggested that there may be several endophenotypes derived from 
neuropsychological test data (Egan et al 2001a). Results from twin and family 
studies have suggested that particularly visuospatial working memory functions, 
related to prefrontal neural systems (Park et al 1995; Cannon et al 2000b; Myles-
Worsley et al 2002), but also verbal working memory functions (Conklin et al 
2000), may be potentially valid endophenotypes to be included in genetic 
analyses. Moreover, the relative risk of impairment in siblings of schizophrenia 
patients is elevated in verbal learning and memory functions that rely on temporal 
brain systems, as well as in tests measuring executive functions (Egan et al 
2001a). Data from studies assessing the relative risk of impairments have shown 
that these impairments exist in several, independent domains of cognitive 
functions also in relatives of schizophrenia patients, which at this point warrant 
including multiple test scores in genetic linkage analyses.  
2.11.3 Quantitative trait loci and schizophrenia 
Thus far, only a few studies have exploited the endophenotypes derived from 
neuropsychological test data in genetic analyses of schizophrenia. Gasperoni et al 
(2003) conducted QTL linkage and association analysis on Finnish twins 
including the region of chromosome 1q that had shown evidence for linkage to 
schizophrenia in two prior Finnish patient samples. The study exploited 
quantitative neuropsychological measures of liability. Analyses with a composite 
measure of liability yielded suggestive evidence for linkage at marker D1S2833 
(P = 0.04). Follow-up analyses of the individual trait measures showed that the 
Visual Span subtest of the WMS-R (Wechsler 1987), an indicator of visual 
working memory function, was uniquely sensitive to marker D1S2833 (P = 
0.007). Association analysis confirmed that allelic variation in D1S2833 is 
associated with variation in visual working memory performance as measured by 
the Visual Span subtest (P = 0.003). These data support the utility of this 
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approach and provide evidence for a susceptibility locus on chromosome 1q 
affecting working memory functioning.  
The Weinberger group (for a review, see Weinberger et al 2001) has worked for 
years with the COMT gene at chromosome locus 22q11, and its association with 
neuropsychological test parameters of prefrontal function. They have repeatedly 
received associations with the Val108/158Met allele of the gene and Wisconsin 
Card Sorting Test and a N-back test (Egan et al 2001b; Goldberg et al 2003), but it 
is possible that the variation in COMT genotype is more strongly linked with these 
cognitive functions than with schizophrenia (Harrison and Weinberger 2005).  
However, there is not yet evidence that the quantitative endophenotypes derived 
from neuropsychological test data, including test variables from attention, verbal 
memory and working memory, and executive functions, concluded by several 
studies as being potentially usable in genetic analyses, would indeed fulfill their 
promise. The present thesis provides one of the first studies for exploring this aim.  
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3    AIMS OF THE STUDY
The general aim of the present thesis was to identify neuropsychological 
endophenotypes in schizophrenia families from two samples collected in Finland: 
a genetic isolate in North Eastern Finland, and a sibpair family sample covering 
the whole geographical area of Finland. Further, the aim was to use these 
endophenotypes in genetic linkage analyses in searching for putative predisposing 
genes for schizophrenia.  
The specific aims were:
Study I To estimate the heritability of various neuropsychological variables, and 
the number of quantitative trait loci (QTL) contributing to them in families with 
schizophrenia. It was assumed that at least moderately heritable cognitive traits 
can be found. On the basis of earlier research on cognitive dysfunction in 
schizophrenia, particularly traits associating with working memory were expected 
to detect a restricted number of contributing loci.  
Study II   To compare performance in neuropsychological tests among the healthy 
family members coming from families with several affected siblings and families with 
only a single case.  The goal of the study was to discover whether the unaffected 
subjects in families with several affected siblings perform worse in the 
neuropsychological tests than the unaffected subjects in families with only one affected 
sibling. It was expected that in families with several affected family members more 
cognitive impairments were found than in families with only one case.  
Study III To study the effect of age at onset and neuropsychological functioning 
in patients with schizophrenia.  It was expected that earlier age at onset is 
associated with impairments in neuropsychological functions. Furthermore, it was 
expected that the association between the impairments and early onset would be 
particularly emphasized in patients with several affected family members.  
Study IV  To link quantitative traits derived from the neuropsychological test 
data with genetic marker data over the whole genome. It was expected that using 
quantitative traits, the significant LOD scores found previously in a genome scan 
of the present study population would at least remain significant or become more 
focused.
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Study V  To search for family clusters with similar neuropsychological test 
performance among families with at least two family members suffering from 
schizophrenia. A family-based cluster analysis was conducted on the 
neuropsychological test performance of the affected and unaffected family 
members. It was expected that at least a cluster with impaired performance and a 
well performing family cluster would be detected. 
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 4  SUBJECTS AND METHODS 
4.1    THE STUDY PROJECT
The present study is a part of the collaborative project “The Genetic 
Epidemiology and Molecular Genetics of Schizophrenia in Finland” run by the 
Department of Mental Health and Alcohol Research and the Department of 
Molecular Medicine at the National Public Health Institute, Helsinki, Finland. 
The general aims of the project were to characterize the epidemiology, 
particularly genetic epidemiology, of schizophrenia in Finland, to understand why 
the disorder occurs in some families but not in others, to investigate genetic and 
environmental risk factors of schizophrenia, and to identify genes predisposing to 
schizophrenia. The principal investigators were professor Jouko Lönnqvist and 
professor Leena Peltonen-Palotie. The study protocol was accepted by the Ethics 
committee of the National Public Health Institute, and by the Ministry of Social 
Affairs and Health. 
4.2 SUBJECTS
From a cohort of all people born in Finland during 1940 to 1976 inclusive, we 
identified 33,731 individuals with a diagnosis of schizophrenia using the data 
derived from three nation-wide computerized health care registers for 1969 to 
1998 inclusive. The Hospital Discharge Register covers all the public and private 
hospitals in Finland, a Nordic country with the population of approximately 5 
million. For each stay, hospital identification code, admission and discharge 
dates, primary diagnosis and up to three subsidiary diagnoses are recorded. The 
discharge diagnoses for each admission are made by the attending physician. The 
diagnoses in the register were coded according to ICD-8 before 1987, DSM-III-R 
for 1987 to 1995, and ICD-10 since 1996. 
The Free Medicine Register and the Pension Register index primary diagnoses for 
state-subsidized outpatient medications, and beginning and ending dates and 
primary diagnoses justifying disability pensions, respectively. Eligibility for a 
medication subsidy or pension must be documented by the treating physician and 
reviewed by another independent physician specialized for this procedure. All 
Finnish citizens have free access to inpatient and outpatient health care and are 
entitled to a state-subsidized outpatient medication and to a state-funded 
disability pension. More than 90% of individuals with psychotic disorders in 
Finland come into contact with the health care system in at least one of those ways. 
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The Population Register contains data on place of birth, residence, marital status, 
census data, and first-degree relatives for each Finnish citizen. Personal 
identification numbers which code the date of birth and sex are unique for each 
individual. By linking these numbers of the affected subjects to the data on their 
family members derived from the national population register centre, we were 
able to construct pedigrees. 
Two samples of subjects with schizophrenia were collected for this population-
based genetic study. The first sample consisted of families with at least two 
siblings with schizophrenia and their first-degree relatives from the whole 
geographical area of Finland (AF).  The second sample comprised patients and 
their relatives from families with at least one member with schizophrenia from an 
isolated region in the northern part of the country (IS). This isolated 
subpopulation originated from 40 families at the end of the 17th century, and 
precise details of subsequent births, deaths, marriages, and moves elsewhere have 
been recorded and preserved by the Finnish Church (Varilo et al 2000). In this 
area, the age-corrected lifetime risk of schizophrenia of 3.2% contrasts with the 
national average of 1.1% (Hovatta et al 1999). To increase homogeneity, the 
sample was restricted to persons with at least one parent born in the isolate area, 
which was enabled by the available genealogical data. Parenthood and sibship 
were ascertained by genetic analyses. The genealogical search has been reported 
in detail previously (Hovatta et al 1999; Varilo et al 2000). 
In both samples, each affected individual was contacted only after the receipt of 
permission from the treating physician most familiar with the subject to begin the 
informed consent process. Only after the affected subject had given a written 
informed consent, the remaining family members were contacted. The collection 
of blood samples followed the recommendations given in the Declaration of 
Helsinki and its amendments.  
All available case note records were collected for those with a diagnosis of 
psychosis in any of the three abovementioned registers. Two psychiatrists, blind 
to the family structure and register diagnosis, assessed independently the best-
estimate lifetime diagnoses for each case, according to the classification of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV, American 
Psychiatric Association 1994). One of the assessors also filled out the Operational 
Criteria (OPCRIT, or OCCPI; McGuffin et al 1991) checklist. Disagreements on 
the assessment of research diagnoses on the lifetime basis were reviewed by a 
third assessor, and a consensus was made.  
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The affected subjects were grouped into six diagnostic liability classes: class 1 
included schizophrenia, class 2 added schizoaffective disorder, class 3 added 
schizophreniform and delusional disorders, brief reactive psychosis, psychotic 
disorder not otherwise specified (NOS), and paranoid, schizoid, and schizotypal 
personality disorders, class 4 added affective disorders with psychotic symptoms, 
class 5 added psychotic disorders due to substance use or general medical 
conditions. Class 0 included all non-psychotic mental disorders.  
All schizophrenia patients were under antipsychotic medication, and in other 
patient groups, antipsychotic medication, antidepressives and anxiolytes were 
common. 
Altogether 975 subjects from 292 families were interviewed using the 
Structured Clinical Interview for DSM-IV (SCID) (First et al 1997), and a 
neuropsychological test battery was administered. Altogether 68 subjects (44 
from the isolate) were excluded from the analyses of the present thesis. The 
reasons for exclusion were 1) high age (80 and above), 2) neurological 
conditions, severe medical comorbidity, or current alcohol or substance use 
disorders, 3) mental retardation, 4) acute psychosis with consequent 
untestability. Table 3 shows the distribution of the abovementioned liability 
classes of the remaining 907 subjects separately for the two subsamples, and 
for gender.  
Table 3. Distribution of the liability classes in the study project samples 
    Isolate (IS) N=625              All Finland (AF) N=282  
    Females  Males    Females  Males 
299   326     136   146 
________________________________________________________________ 
Mean age (SD) 50.7 (11.8) 48.7 (11.5)   50.8 (11.8) 48.2 (10.2) 
Liability class (%) 
 1   56 (18.6) 122 (37.1)   44 (32.4) 46 (31.5) 
 2   14 (4.7)  21 (6.4)    8 (5.9)  9 (6.2) 
 3   15 (5.0)  21 (6.4)    3 (2.2)  8 (5.5) 
 4   33 (11.0) 12 (3.6)    3 (2.2)  10 (6.8) 
 0   71 (23.6) 51 (15.5)   24 (17.6) 26 (17.8) 
Healthy   110 (36.5) 99 (30.1)   54 (39.7) 47 (32.2) 
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All subjects from the families gave a written informed consent for the study 
protocol comprising a diagnostic research interview and neuropsychological 
testing. Both patients and their family members were interviewed using the 
Structured Clinical Interview for DSM-IV (SCID-I for axis I disorders and SCID-
II for axis II disorders). All the interviewers were trained in a similar manner for 
the use of these instruments. The final consensus diagnoses were based on the 
data collected from the records, the OPCRIT process, and the SCID interview. 
For each of the five studies comprising the present thesis, different inclusion and 
exclusion criteria were applied when subsamples derived from the described 
project were exploited. 
4.2.1 Subjects in the Study I 
The Study I comprised 264 subjects from 131 of the 397 families identified 
from the isolated region in the northeastern part of Finland.  The Study I was 
conducted when subjects from 131 families had been unselectively processed 
in the still ongoing study. Both parents of 85 (65%) families were born in the 
isolated region, and in 116 (89%) families, both parents were born within the 
larger region defined by the border municipalities. In the remaining families, 
one parent was born in the core region, and the other elsewhere in the 
northern or central Finland.  
Based on the consensus process and interview, 137 subjects (44 females, mean 
age 48.5, SD 7.6, and 93 males, mean age 45.6, SD 7.6) had schizophrenia or 
schizoaffective disorder, 34 subjects (17 females, mean age 46.8, SD 6.9, and 
17 males, mean age 45.8, SD 5.6) had other mental disorder, including other 
psychotic (except current alcohol induced psychoses) and non-psychotic 
disorders (except mental retardation), and 93 subjects (53 females, mean age 
48.0, SD 7.3, and 40 males, mean age 46.1, SD 8.2) had no mental disorder. 
4.2.2 Subjects in the Study II 
The Study II included only subjects who did not receive any psychiatric diagnosis 
in the consensus process. The subjects were drawn from the families studied in 
the isolate sample, and divided into singleton and multiplex groups based on the 
following criteria.  
42
A singleton family included 1) only one sibling with a consensus diagnosis of 
schizophrenia (schizoaffective disorder and schizophreniform disorder not 
included), and the patient is interviewed and neuropsychologically tested, 2) 
at least one interviewed and tested sibling without any DSM-IV diagnosis as 
assessed by the SCID, 3) no first-degree relatives with any psychotic disorder.  
A multiplex family included 1) at least one sibling with a consensus diagnosis 
of schizophrenia, and at least one sibling with schizophrenia (schizoaffective 
disorder and schizophreniform disorder not included), or another nonaffective 
psychosis, all interviewed and neuropsychologically tested, 2) at least one 
interviewed and tested sibling without any DSM-IV diagnosis as assessed by 
the SCID. 
The final sample of the Study II comprised 31 healthy siblings from 27 
singleton families, and 67 healthy siblings from 49 multiplex families. In the 
singleton families, the proband was suffering from schizophrenia. In the 
multiplex families, at least one sibling had schizophrenia, and at least another 
with this diagnosis or another non-affective psychotic disorder. No diagnosis 
of mental disorder, lifetime or current, was assigned to the siblings included 
in the study, based on the SCID interview and information from the registers, 
and none was taking psychopharmacological medication. None of the 
singleton families had a parent with a psychotic disorder. In 18 multiplex 
families, one parent had a psychotic disorder, and in three families, both 
parents were affected. In the multiplex group there were significantly more 
females than in the singleton group (chi2=6.6, p=0.01). Age, education years, 
or estimated intelligence quotient (IQ) did not differ between the groups 
(Study II: Table 1, page 624). The number of siblings in the family of origin 
differed significantly between the study groups. The mean number of siblings 
was 5.5 (SD 2.7) in the singleton group, and 7.7 (SD 2.8) in the multiplex  
(t=-3.4, p=0.01). In 41% of the singleton group, there were 2-4 siblings in the 
family, in 41% 5-8, and in 18% nine or more. The respective figures in the 
multiplex group were 17%, 47% and 36%.  
4.2.3 Subjects in the Study III 
The Study III included patients suffering from schizophrenia, drawn from the 
isolate sample and all Finland sample. From 275 families, altogether 411 patients 
and 561 family members were interviewed using the Structured Clinical 
Interview for DSM-IV (SCID) (First et al 1997), and the neuropsychological test 
battery was administered. 
43
From the Study III, we excluded 41 patients, who had a schizophrenia spectrum 
diagnosis in the registers but who were assigned a lifetime consensus diagnosis of 
bipolar disorder, and 11 patients who received a consensus diagnosis of a 
nonpsychotic disorder instead of psychotic schizophrenia spectrum disorders. 
Furthermore, we excluded 52 patients with schizoaffective disorder and 20 
patients with schizophreniform disorder. This left us with 287 patients with 
schizophrenia. Of them, 35 either did not give a valid test performance or were 
untestable (acute psychotic state, severe medical comorbidity). Of nine patients, 
reliable information of the age of onset was not received, and four patients were 
excluded because of very early age of onset (7-12 years).  
The Study III thus comprised 237 subjects with the diagnosis of schizophrenia 
from 208 families. Of the patients, 81 were women and 156 were men (p<0.001), 
thus reflecting a slight overrepresentation of males (66% vs. 58% in the 
registers). The age of women (mean 45.4, SD 8.4) and that of men (mean 45.0, 
SD 7.5) were similar. The course of the illness was chronic in 71% of women and 
74% of men (data derived from the OCCPI). 
Table 1 of the Study III (page 216) shows the demographic data of the study 
sample. Information of the age of onset was derived from the case notes as one of 
the OCCPI-items. The case notes were comprehensive and covered the inpatient 
and outpatient phases of the whole illness history of the patients. The age of onset 
was defined as the earliest age at which medical advice was sought for occurrence 
of psychiatric symptoms, or at which the symptoms began to cause subjective 
distress or impair functioning. The mean age of onset in the final sample was 23.2 
years (SD=5.7) with no difference between women (mean 23.0, SD 5.7) and men 
(mean 23.3, SD 5.7). 
4.2.4 Subjects in the Study IV 
The sample of the Study IV was obtained by linking the data derived from 
neuropsychological tests with the genotypes of genome-wide polymorphic 
microsatellite markers. There were 168 nuclear families with at least two 
individuals having both the detailed phenotypic investigation and molecular 
genetic data. The sample thus comprised 598 individuals with valid 
neuropsychological test data. Of them, 179 had a diagnosis of schizophrenia 
(mean age 45.8, SD 8.3; 65 females and 114 males).  Furthermore, 419 subjects 
were siblings or parents (mean age 52.4, SD 11.9; 218 females and 201 males), 
including both subjects with other psychiatric diagnoses than schizophrenia, plus 
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subjects to whom no diagnosis was assigned. However, in this study, the 
phenotype was not based on the categorical diagnosis but on the continuous 
variables that the cognitive tests provided. 
One hundred and ten families (65%) came from the internal isolate (IS) in 
northeastern Finland. Although many individual nuclear families of the IS sample can 
be linked to larger pedigrees (Hovatta et al 1999; Paunio et al 2001), due to 
incompleteness of the data with a significant amount of missing information, analysis 
of only IS core families was considered to be the most appropriate approach for the 
current study. The remainder of the families lived elsewhere in Finland (AF). The 
correct family structures were confirmed by Mendelian inheritance analysis of 
various multiallelic markers within the families (Paunio et al 2001). 
The twin pairs, whose neuropsychological test data were used as control data, 
were originally recruited to represent a control sample without any mental 
disorder in a study examining the inheritance of neuropsychological dysfunction 
(Cannon et al 2000b), and structural abnormalities of the brain (Cannon et al 
2002a) in twins discordant for schizophrenia. For the Study IV, every other MZ 
twin and DZ co-twin was randomly selected, and the sample thus comprised 56 
individuals (26 females) with well corresponding mean of age and sex 
distribution to those in the family sample. 
4.2.5 Subjects of the Study V 
Of those multiply affected families from the whole geographical area of Finland, 
who already had given the blood samples, a subsample was targeted for collection 
of more detailed phenotypic information. This sample was selected randomly 
based on the data from the registers and the OPCRIT process.  
A total of 281 subjects from 54 families fulfilled the inclusion criteria for the 
Study V, and the families thus included at least two siblings with schizophrenia, 
schizoaffective disorder or schizophreniform disorder, and at least two siblings 
without these disorders. Altogether 16 patients were excluded because of being 
too psychotic (n=6), having a current substance use diagnosis (n=6), or being 
mentally retarded (n=4). Of the family members to whom no psychiatric 
diagnosis was assigned for their lifetime, 6 were excluded because of high age, or 
for a defect in vision or hearing. The final sample thus comprised 165 subjects 
with a psychiatric diagnosis and 94 unaffected family members from 54 families.  
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Of the 165 subjects with a diagnosis, altogether 82 subjects had schizophrenia, 
while 13 subjects suffered from schizoaffective disorder, 10 from 
schizophreniform disorder and 12 from bipolar disorder. A nonpsychotic disorder 
was assigned to 48 individuals. The 94 unaffected subjects did not get any current 
or lifetime psychiatric diagnosis. In 51 families, at least one of the patients 
included in the analysis suffered from pure schizophrenia. In the remaining three 
families, at least one subject with schizoaffective or schizophreniform disorder 
was included.  
All families from which the subjects for the Study V were drawn, represent 
familial schizophrenia, as in each of them there were at least one sibling with a 
diagnosis of pure schizophrenia, plus at least one other sibling with 
schizophrenia, schizoaffective disorder or schizophreniform disorder.  
4.3 THE NEUROPSYCHOLOGICAL TEST PROCEDURES 
The neuropsychological tests were administered to the subjects in fixed order. 
The battery included two blocks. If the subject was unable to complete the whole 
battery in one day, the second block was administered next day. The subjects 
were tested in the local field-work offices, or at their homes, or in some cases in 
hospital.  All examiners were psychologists or advanced psychiatric nurses 
experienced with severely ill psychiatric patients. They received extensive 
training with the test battery before the study began, and sessions with feedback 
and supervision were organized regularly thereafter. All scoring was done by 
experienced psychologists. 
The Digit Span subtest of the WMS-R (Wechsler, 1987) was used to assess 
auditory attention (forward condition) and verbal working memory (backward 
condition).The Digit Span test is an auditory task in which the examiner reads out 
numbers at one per second. The forward task requires the participant to repeat the 
numbers verbatim. In the backward task, the numbers need to be repeated in 
reverse order. The number series increases one at a time until the participant fails 
two trials consecutively of the same series length. According to Finnish 
normative data, the test-retest reliability coefficients of the Span subtest have 
varied from .74 to .82, depending on age.  
The Visual Span subtest of the WMS-R (Wechsler, 1987) was used to assess 
visual attention (forward condition) and visual working memory (backward 
condition).  In the Visual Span Forward subtest, the examiner points at squares 
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printed on a sheet, and the subject then has to point at the same squares in the 
same order. In the Visual Span Backward subtest, the subject has to point at the 
squares in reverse order. As in the verbal span task, the number of stimuli 
increases by one, until a failure occurs in two tests of equal length. According to 
Finnish normative data, the test-retest reliability coefficients of the Visual Span 
subtest have varied from .72 to .80, depending on age. 
Verbal learning and memory were assessed with the California Verbal Learning 
Test (CVLT) (Delis et al 1987), which examines recall and recognition of word 
lists over a number of trials. First, the subject is presented with a list of 16 words 
(four words in four semantic categories). The examiner reads aloud the list five 
times, and the subject is then asked to repeat all the recalled words in a free order. 
An interference list of 16 new words is then presented, after which the subject is 
immediately asked to recall the words from the original list, first freely and then 
with cues from the four categories used in the list (fruits, clothes, spices, and 
tools).  After an interval of 20 to 30 minutes both free and cued recall, and 
recognition of the original list are assessed. This procedure yields several 
parameters for use as independent variables: levels of total recall and recognition, 
semantic and serial learning strategies, degree of distractibility, retention of 
information, and recall errors.  
The Studies I-V report the following variables induced from the CVLT: total 
recall, semantic clustering, learning from the beginning of the list (primacy) and 
from the end of the list (recency), recall errors (perseverations and intrusions), 
delayed recall, and recognition (discriminability). No reliability data for Finnish 
subjects exists, but the split-half reliability of the CVLT is .77 to .86, according to 
the manual of the test (Delis et al 1987).  
Four subtests of the Wechsler Adult Intelligence Test – Revised (WAIS-R) 
(Wechsler 1981) were used. Verbal abilities were measured with the Vocabulary 
and Similarities subtests.  Vocabulary is considered as one of the best single 
measure of general ability, and it is usually well preserved in different 
neurological conditions (Lezak et al 2004). The subject is asked to explain the 
meaning of a list of words. The Similarities subtest is a task of abstraction and 
concept formation. The subject has to find a shared meaning for a pair of words, 
and the best scores are given for forming the most general concepts. These two 
tasks are included in the Verbal Scale of the WAIS-R. The Block Design and the 
Digit Symbol subtests belong to the Performance Scale. Both tasks have a motor 
component as the trials are timed. The former subtest is a measure of visuospatial 
reasoning and abstraction. The subject constructs shapes with cubes, following a 
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picture as a model. The latter subtest measures psychomotor performance, the 
task being to fill in as many blank spaces as possible in 90 seconds with symbols 
paired to numbers. The key for pairing each number with a symbol is printed 
above the trial rows. According to Finnish normative data, the test-retest 
reliabilities for Vocabulary, Similarities, Block Design and Digit Symbol have 
been .89-.95, .69-.88, .78-.83, and .82-.86, respectively, depending on age.  
The Span tasks from the WMS-R (Wechsler 1987), the WAIS-R (Wechsler 1981) 
tasks, and the CVLT (Delis et al 1987) were included in the studies I-III and V. In 
addition, the Study V included the Logical Memory story A, of the WMS-R 
(Wechsler 1987), immediate and delayed, which was used to assess recall and 
retention in a story format. Furthermore, in the study V, visual memory was 
measured by the Visual Reproduction subtest of the WMS-R (Wechsler 1987) 
immediate and delayed. In Finnish normative data, the test-retest reliabilities of 
these subtests have varied with age from 0.84 to 0.91, and 0.31 to 0.34, 
respectively. The Study V included also the Controlled Oral Word Association 
Test (COWAT) (Benton and Hamsher 1989), which was used to assess verbal 
fluency. The quantity of words the subject produces in one minute, both with 
words beginning with a designated letter (S,K), and within a category (animals), 
was assessed. No reliability data for Finnish subjects are availabe. 
Study IV included the WMS-R Span tasks, the CVLT, and the Stroop (Golden 
1978). From the Stroop, the interference score was computed and used as a 
measure of executive function. For the Stroop, no reliability data are available for 
Finnish subjects. Because standardized scores were not available for all 
neuropsychological tests, raw scores from the tests were used in all Studies. Table 
4 lists the variables used in the Studies I-V.  
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Table 4. Test variables included in the Studies I-V 
          I II III IV V 
Intelligence 
WAIS-R (Wechsler 1981)
Vocabulary       x x x  x 
Similarities       x x x  x 
Block Design      x x x  x  
Digit Symbol      x x x  x 
Attention  
WMS-R (Wechsler 1987)
Digit Span forward     x x x x x 
Visual Span forward     x x x x x 
Working memory 
WMS-R (Wechsler 1987)
Visual Span backward    x x x x x 
Visual Span backward    x x x x x 
Verbal memory functions 
CVLT (Delis et al 1987)
Total recall       x x x x x 
Semantic clustering     x x x x x 
Intrusions       x x x x 
Perseverations      x x x x 
Delayed memory      x   x 
Primacy        x x x  
Recency        x x x 
Recognition       x x x x x 
WMS-R (Wechsler 1987)
Logical Memory          x 
Visual Reproduction         x 
Executive functioning 
Stroop (Golden 1978)
Interference           x 
COWAT  (Benton and Hamsher 1989)      
Letters S and K          x 
Animals            x 
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4.4 STATISTICAL ANALYSES 
In all difference testing analyses, the probability level p<0.05 indicated statistical 
significance. These analyses were performed using the S-Plus statistical software, 
version 3.4 (S-Plus 1996). 
4.4.1 Statistical analyses in the Study I 
In the Study I, polygenic heritability, the proportion of variance due to the 
polygenic effect, was estimated using the Solar algorithm (Almasy and Blangero 
1998). Heritability refers to the proportion of variance for e.g. a disorder that is 
estimated to be attributable to genetic factors.  
The number of trait loci and their effects, and the effects of covariates on the 
ncognitive traits were estimated using oligogenic segregation analysis. Reversible 
jump Markov Chain Monte Carlo (MCMC) methods implemented in the Loki 
computer program (Heath 1997) were applied. Loki analyses quantitative traits 
observed on large pedigrees, however, the Study I exploited data from nuclear 
families only. The method allows for variation in the number of QTLs and in their 
linkage status. In the Study I, the raw scores from the neuropsychological tests 
were considered as the phenotypes, instead of the dichotomous affected vs. 
unaffected diagnosis.  
The assumed model relates the phenotypes (y) to an additive function of covariate 
and genotype effects. The model for each trait is as follows: y = ?+X?+?ki=1
Qi?i+e, where ? is the overall population mean, ? (m x 1) is the vector of the 
covariate effects, ?i (2 x 1) is the vector of the effects for the ith QTL,  e (n x 1) is 
the vector of the normally distributed residual effects, k is the number of QTLs in 
the model, and X (n x m) and Qi (n x 2) are incidence matrices for the covariates 
in all individuals and QTL effects, respectively. The MCMC analysis 
produces a sample from the posterior distribution of all unknown parameters 
in the model (?, ?, k, Qi, ?i , e). Prior distributions of parameters were generally 
normal, except that the prior for k was uniform between zero and sixteen, and 
independent normal priors (N(0,?)) were assigned for two components of ?i.
In the QTL models, the proportion of variance due to QTLs is reported. This is 
comparable to the polygenic heritability, but does not include the residual 
polygenic part of the variance, which remains after accounting for the QTLs. The 
estimation involves a stochastic element, and no single model is identified to the 
exclusion of another. Instead, it produces a series of models. 10,500 iterations for 
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each trait were run, omitting the first 500. The convergence of the iterations was 
checked graphically.  The 95% credibility limits and posterior means of the 
parameters from empirical posterior distribution produced by the MCMC 
algorithm were obtained.  
Age, sex, and verbal ability as measured with the WAIS-R Vocabulary subtest, 
were used as covariates in the analyses.  
4.4.2 Statistical analyses in the Study II 
The significance of the differences in neuropsychological functioning between 
the unaffected subjects from families with one schizophrenia patient or with two 
or more patients was tested using linear mixed effects models. To control for 
intrafamilial correlation, as some subjects came from the same family, family was 
included as the random effect. Belonging to a singleton or multiplex family, 
number of siblings in the family, and sex, were included as fixed effects. The 
significance of the fixed effects was determined using a Wald-type test of fixed 
effect parameter estimates (t-statistics).  
For comparing the test results with the normative Finnish data, the raw scores were 
transformed to age-corrected standard scores using available Finnish normative 
data tables for WMS-R (Wechsler 1996) and WAIS-R (Wechsler 1992). The 
differences of the standardized test scores from the national norm means were 
tested using one-sample t-test, with the national norm mean as the test value. These 
data were available for the WMS-R (Wechsler 1987) and for the WAIS-R 
(Wechsler 1981). In the WMS-R span tasks, the mean for the standard score 
distribution is 0, and the standard deviation is 1. In the WAIS-R, the respective 
figures are 10 and 3. The effect sizes comparing standardized test scores with the 
normative mean were calculated using Cohen´s d (Cohen 1988). The analyses were 
made separately for the singleton and multiplex siblings. Furthermore, the effect 
sizes comparing the standardized scores of the singleton and multiplex groups were 
calculated. For the CVLT, normative data were not available. 
4.4.3 Statistical analyses in the Study III 
The associations between age of onset and the neuropsychological test variables 
were examined using linear mixed effect models. Age of onset was treated in the 
models as a continuous variable, ranging from 13 to 44 years. Family was included 
as a random effect, as the subjects came in part from the same families. Age 
(years), sex, course of the illness (chronic vs. episodic), and age of onset (years) 
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were included as the fixed effects. Furthermore, the number of affected members in 
the family was included in the models as a fixed effect in order to detect whether 
the familial loading, as measured with the number of first-degree relatives with a 
psychotic disorder, modifies the effect of the age of onset on the cognitive 
functions. The information of the illness of the first-degree relatives was obtained 
from the registers. Furthermore, additional models with all test variables with the 
abovementioned random and fixed effects plus duration of the illness (tertiles from 
age of onset subtracted from the age at testing in years) were run. 
4.4.4 Statistical analyses in the Study IV 
SOLAR, an oligogenic variance-component linkage method incorporating the 
variance component program FISHER, was applied for the quantitative trait locus 
(QTL) linkage analysis for the Study IV (Lange et al 1988). Preliminary 
statistical analyses of the neuropsychological features, including descriptive 
statistics as well as bivariate correlation analysis, were performed using SPSS 
software (SPSS Inc, Chicago, USA). As variance-component based analysis may 
be vulnerable to deviation from multivariate normality and, in particular, to high 
levels of kurtosis in the trait distribution, transformations towards normality were 
applied for perseverations, intrusions, and executive function; semantic 
clustering, and for recognition memory.  
All genetic analyses included an ascertainment correction in which individuals 
with schizophrenia were labeled as the proband. The mean of the control sample 
using the twin data was applied as a constraint, and age and gender terms were 
included as covariates. The primary interest of the study was to analyze the 
complete study sample (Com). However, owing to the potential difference in the 
genetic background of the 110 families collected from an internal isolate 
representing a more restricted gene pool, separate analyses were also run for the 
IS families and AF families. 
4.4.5 Statistical analyses in the Study V 
4.4.5.1 Cluster analysis 
The variables used in the Study V cluster analysis included 17 neuropsychological 
test variables together with the age and the sex of the subjects. With a total of M = 
19 variables and N = 259 subjects, the data formed an M × N matrix x = (xik),
where xik is the value of the ith variable for the kth subject.  
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The clusters were obtained by treating families as single objects whose 
dissimilarity was measured by the pairwise test performance differences between 
the family members. The families were clustered using a complete-linkage 
clustering algorithm. Each variable was normalized by subtracting the mean value 
and dividing by the standard deviation. The normalization was done to ensure that 
each variable contributes equally to the clustering procedure. In the sense of this 
distance measure, two clusters were close when all subjects in both clusters 
showed close to similar test performance. 
The clustering followed three steps. In the first step, the initial clusters were 
defined by the families. In the second step, the two clusters with the smallest 
inter-cluster distance were merged into one larger cluster. Then, the steps 2 and 3 
were repeated until a desired number of clusters remained. Figure 1 of the Study 
V, page 4/12, demonstrates this procedure.  
4.4.5.2 Visualization of clusters 
The Study V introduces a visualization technique that helps in identifying 
candidate clusters and also gives an overall picture of the main differences 
between the produced clusters as measured by all variables simultaneously. The 
method gives information about the dynamics of the clustering process and the 
characteristics of the candidate clusters. The Figure 2 in the Study V (on page 
5/12) presents the data matrix as what is called the "color histogram" with the 
rows corresponding the variables and the columns correspond the subjects. The 
values of the neuropsychological tests and other variables are visualized using 
color coding.  
The lower part of Figure 2 of the Study V (page 5/12) visualizes the actual 
clustering process using the dendrogram. The history (vertical direction) of the 
mergings is shown from the beginning (one family in each cluster) to the end (all 
families in one cluster). By simultaneously exploring the two images, a 
reasonable value for the number of clusters can be found and the characteristics 
of the cluster solution visualized in a useful manner. It is also helpful to monitor 
the inter-cluster distance measure for possible large jumps which indicate that 
two distant clusters are being merged (Figure 3, Study V, page 6/12).  
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4.4.5.3  Difference testing between the clusters  
Further, after the cluster analysis, the proposed family clusters were examined for 
differences on demographic and neuropsychological measures. In addition, the 
patients included in the clusters were examined for the differences in clinical 
variables as evaluated by the OPCRIT (premorbid social adaptation, response to 
neuroleptic treatment, chronicity, age of onset) of the disorder. In comparing the 
demographic and clinical variables, the Chi-square test, or t-test, both two-tailed, 
were applied. The differences in the quantitative neuropsychological measures 
were analyzed using the linear mixed effects model, which takes into account the 
dependence between the subjects, who, a priori, came from the same families. 
Thus, family was included as a random effect in all models with age and sex as 
the fixed effects. In addition, post hoc models were conducted with education 
years as an added fixed effect, a known confounder for cognitive functions.  
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5   RESULTS  
5.1   HERITABILITY OF COGNITIVE FUNCTIONS AND THE NUMBER OF THEIR 
RESPECTIVE LOCI  (STUDY I) 
5.1.1 Heritability  
In the polygenic model with age, sex and verbal ability as covariates, 
significant heritability was obtained for the following neurocognitive traits: 
verbal working memory (h2=0.42, p<0.003), semantic clustering (h2=0.28, 
p<0.03), recall errors (intrusions) (h2=0.66, p<0.001), recognition 
(discriminability) (h2=0.49, p<0.01), and visuospatial ability (h2=0.48, 
p<0.04). Visual working memory and concept formation showed a trend of 
significance (h2=0.36, p<0.06 and (h2=0.38, p<0.06, respectively). Verbal 
ability, with age and sex as the only covariates, showed significant heritability 
(h2=0.62, p<0.0006) (Study I, Table I, page 486). 
5.1.2 Number of QTLs 
The posterior probabilities for one or more loci, and the number of loci 
contributing to a trait are shown in Table III of the Study I (page 487). The 
neurocognitive variables with a mean number of loci very close to one, together 
with a high posterior probability for at least one locus, were verbal working 
memory and visual working memory. High probabilities for at least one locus, 
and the mean number of contributing loci less than two, were found in concept 
formation, intrusions, perseverated responses, and visuospatial ability. Semantic 
clustering had a high probability for at least one locus, and slightly over two loci 
contributed to it. The traits, which provided little evidence for genetic 
contribution (posterior probability for at least one locus less than 50%) were 
attention, verbal memory, and visuomotor speed.  
The measures with a high posterior probability for one locus were assessing verbal 
working memory (73%) and visual working memory (70%).  The ability to use 
semantic clustering while learning was contributed by only one locus with a 
posterior probability of 99%. Verbal concept formation and visuospatial ability, as 
measured with the WAIS-R subtests Similarities and Block Design, respectively, 
supported genetic contribution for a one gene locus, with corresponding posterior 
probabilities for one locus of 97% and 84%. 
55
One or two loci with posterior probabilities for one locus around 90% 
contributed to forgetting what had already been produced in the word list test 
(perseverations), and also to the function of producing words that did not exist 
on the list (intrusions). Two loci with a posterior probability 100% for at least 
one locus contributed to recalling words from the end of the word list 
(recency), implying poor working memory and impairment in learning ability.  
The posterior probability for no quantitative trait loci contributing to attention 
measures was around 50%. In addition, declarative verbal memory (total 
words recalled from the list over five trials), and an ineffective learning 
strategy (primacy) did show very small genetic contributions. Psychomotor 
speed revealed the largest probability of negative genetic contribution (72% 
for no locus).  
5.2   EFFECT OF FAMILIAL LOADING ON THE COGNITIVE FUNCTIONS AMONG   
RELATIVES OF SCHIZOPHRENIA PATIENTS (STUDY II) 
In the linear models with family as a random effect, a significant difference 
between the singleton and multiplex families was found in the backward visual 
span, assumed to measure immediate visual memory and components of 
visuospatial working memory: the healthy subjects of the multiply affected 
families performed worse than those of the singleton families (t=-2.06, p=0.04). 
No other significant differences were detected in the linear models (Study II, 
Table 2, page 625). 
The possible sex by group interactions were examined, and significant 
interactions were found in one variable (primacy in the CVLT). The follow-up 
analyses by sex revealed that females in the multiplex group scored significantly 
higher than females in the singleton group in remembering words from the 
beginning of a word list (primacy) (t=-2.2, p=0.04). For males, no significant 
singleton-multiplex differences were found. We then repeated all linear mixed 
effects model analyses separately for each sex, but the results remained similar. 
The effect of family size was nonsignificant in all models. 
In comparisons of the standardized scores of the span tests with the available 
Finnish normative data, healthy siblings from the multiplex families were found 
to perform significantly worse than the norm mean in all WMS-R forward and 
backward span tests Although the healthy siblings from the singleton families 
scored below the norm mean in all span tests, the difference was not significant. 
In the singleton group, the effect sizes comparing standardized test scores with 
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the normative mean were small in all span test variables (d<0.3). In the multiplex 
group, the effect sizes were moderate in the forward and backward visual span 
(d=0.5 and d=0.6, respectively), but small in the verbal span tasks (d<0.3). The 
between group effect size was moderate for the backward visual span (d=0.5), 
and small for all other variables.  
In the subtests from the WAIS-R, both groups scored above the norm mean in the 
Digit Symbol subtest, and the siblings from the multiplex families scored better 
than the norm mean in the Vocabulary subtest (Study II, Table 3, page 626). 
However, only small effect sizes (d<0.5) were received from the WAIS-R tests as 
compared with the normative mean.  
5.3 EFFECT OF AGE OF ONSET ON COGNITIVE FUNCTIONS IN SCHIZOPHRENIA 
(STUDY III)
5.3.1  Effect of age of onset 
In the linear mixed effect models, lower scores on four cognitive functions were 
significantly associated with earlier age of onset (Study III, Table 2, page 217). 
These functions were verbal learning and memory (total recall from trials 1 to 5 
in the CVLT) (coefficient for the effect of how much each increasing year in the 
age of onset changes the value of the test score =0.483, SD=0.14, p=0.002), using 
semantic clusters as a learning strategy (effect coefficient=0.023, SD=0.01, 
p=0.02), recognition memory (effect coefficient =0.256, SD=0.15, p=0.05), and 
making errors during recall (intrusions) (effect coefficient = -0.033, SD=0.01, 
p=0.007).  
5.3.2  Fixed effect contributions 
Course of the illness (chronic vs. episodic) contributed to the measured four 
intelligence functions (all p-values < 0.03).  Chronicity also showed a significant 
negative effect on verbal learning and memory (effect coefficient =-6.245, 
SD=1.8, p=<0.001), semantic clustering (effect coefficient =-0.287, SD=0.11, 
p=0.02), delayed verbal memory (effect coefficient =-1.723, SD=0.48, 
p=<0.001), recognition memory (effect coefficient =-5.300, SD=1.62, p=0.002), 
and making intrusions (effect coefficient =0.348, SD=0.14, p=<0.02), but it did 
not eliminate the effect of age of onset on these variables. Including duration of 
the illness into the models did not change the results, and this variable did not 
contribute significantly to any of the measured cognitive functions. The number 
of affected first-degree relatives in the family showed a significant negative effect 
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on visual working memory (effect coefficient =-0.27, SD=0.13, p=0.04) and on 
verbal ability (effect coefficient =-1.80, SD=0.83, p=0.04), and on psychomotor 
speed (effect coefficient =-1.31, SD=0.61, p=0.03). 
5.4 GENOMEWIDE QTL-ANALYSIS OF COGNITIVE TRAIT COMPONENTS IN 
SCHIZOPHRENIA (STUDY IV) 
Prior to conducting the linkage analyses, we performed preliminary statistical 
analyses on the variables derived from the neuropsychological test data,  
including estimation of heritability of the cognitive traits, calculation of the 
descriptive statistics, and the correlations between the traits. Significant 
heritability estimates were received for all traits (data not shown). Furthermore, 
the mean performance of the study sample was inferior to that of the control 
sample (Study IV, Table 1, page 1694). The affected probands generally 
performed worse than their relatives, and the mean performance of the latter was 
also below that of the general population (data not shown). Correlations between 
the transformed traits were sought by bivariate correlation analysis of all 
individuals of the study sample. The strongest correlation was observed among 
the different indices of memory function: verbal learning and semantic clustering 
(0.66; p= 0.000001), verbal learning and delayed memory (0.69; p=0.000001), 
and semantic clustering and delayed memory (0.59; p=0.000001) (Study IV, 
Table 2, page 1695). 
5.4.1 Genomewide Search 
In the genome-wide search for QTLs for the neurocognitive functions, our 
primary interest was the analysis of the complete study sample (Com). However, 
owing to the potential differences in the genetic backgrounds of families collected 
from an internal isolate, representing a more restricted gene pool, we also 
analyzed separately the families from the internal isolate (IS) and from the rest of 
the country (AF). 
Several quantitative parameters of verbal learning and memory were found to be 
linked to chromosome 4q13-25 within a 30-cM region. The best individual two-
point and multipoint LOD score values, as presented by SOLAR (Z and Zmp, 
respectively), for the complete study sample (Com) were obtained for delayed 
memory to 4q21 (Z = 3.01 to D4S2361; Zmp = 3.84) (Study IV, Table 3, page 
1696). Both families from the internal isolate and elsewhere from Finland 
apparently contributed to these findings, despite slight variations in the relative 
LOD score values even with nearby locating markers (Study IV, Table 3, pages 
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1696-1697). Based on variance-component analysis, variation on 4q would 
account for 33%, 33% and 32% of the variation in delayed memory, semantic 
clustering and verbal learning, with a residual additive genetic component of 
12%, 17% and 20%, and a random environmental contribution of 38%, 33% and 
26%, respectively.  
Among the measures for attention and working memory, the best evidence of linkage 
was obtained with visual working memory to chromosome 2q36. A suggestive 
evidence for linkage was found in the complete study sample at D2S1363 and was 
contributed to by both AF and IS families (Study IV, Table 3, page 1696). According 
to variance-component analysis, variation in the 2q would account for 21% of the 
variation in visual working memory, with a residual additive genetic component of 
15% and a random environmental contribution of 49%.  
Some evidence of linkage also emerged for executive function on chromosome 
9p22, for recognition memory on 10p13 and for visual attention on 15q22 in the 
complete study sample (Study IV, Table 3, page 1696).  Families from the IS 
sample contributed most to the evidence of the linkage signal on 10p13 and 
15q22, and from the AF sample to the signal on 9p22, respectively. In IS families, 
semantic clustering showed some evidence of linkage to chromosome 1q42, and 
in the AF families measure of intrusions was suggestively linked to 1q32 (Study 
IV, Table 4, pages 1697-1698). A genomewide maximum LOD score of 3.05 was 
obtained in the AF families for delayed memory to D8S1113 on 8q12.  
Compared with the QTL analysis, application of the clinical diagnosis greatly 
reduced the linkage signal in the loci putatively revealed in the present study 
(Study IV, Table 3, page 1696), reflecting the capacity of the quantitative traits to 
extract maximal information from the study sample. 
5.4.2 Genomewide p-values 
In order to assess the relative significance of the most important findings of the 
current study, we permutated some of the neuropsychological functions and 
recalculated the data for genome-wide scans using the permutated phenotypes. 
All adjustments, including adaptation of age and gender as covariates, were 
identical to those used in the original data analysis. The phenotype permutation 
was confined to the family members having both phenotype and genotype data.  
In 1000 permutated genome scans with visual working memory, we found 
maximum two-point LOD scores ? 2.80 93 times, which resulted in an empiric p-
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value of  0.093.  For functions related to verbal learning and memory, a maximum 
two-point LOD score ? 2.96 was found 26 times for verbal learning (p = 0.026), a 
LOD score ? 2.86 143 times for sematic clustering (p= 0.143), and a LOD score ?
3.01 31 times for delayed memory (p=0.031). Thus, verbal learning and delayed 
memory were the functions providing statistically the most significant evidence of 
linkage in terms of the empiric p-value in the current study.  
5.5 COGNITIVE CLUSTERS AMONG FAMILIES REPRESENTING FAMILIAL 
SCHIZOPHRENIA (STUDY V)
5.5.1 The cluster solution 
Three clusters of families were successfully identified from the study sample. The 
first cluster comprised 94 subjects from 17 families, the second cluster 50 
subjects from 12 families, and the third cluster 115 and 25. Adding more 
neuropsychological test variables or leaving out the sex or the age of the subjects 
had little effect on the solution.  
The data image (Study V, Figure 2, page 5/12) indicated that the overall 
performance of the subjects was higher in the first cluster than in the second, and 
that the performance in the third cluster was between the other two. The three 
clusters were therefore identified as consisting of subjects that were relatively 
well-performing, impaired and intermediate, respectively. A three cluster solution 
is supported by the homogeneity of the within-cluster test performance patterns of 
the proposed groups (Study V, Figure 2, page 5/12). As shown by the 
dendrogram in the lower part of the figure, the two-cluster solution would 
combine the impaired and the intermediate clusters, and the four-cluster result 
would divide the well-performing cluster into two subclusters one of which is 
very small, consisting only of six families. Stopping the merging process even 
earlier does not appear to suggest any interesting alternative cluster solutions. 
Note also the jump in the distance function of Figure 3 (Study V, page 6/12) after 
three clusters.  
5.5.2 Demographic and clinical characteristics 
The three clusters did not differ by age or sex distribution. The well performing 
cluster had significantly more years of education than the two others (p <0.001 in 
contrasts versus both other clusters). Overall, the clusters did not differ in clinical 
characteristics, except that the well-performing cluster showed better premorbid 
adaptation than the intermediate cluster (p = 0.04). The age of onset did not differ 
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between the clusters (mean 25.9, SD 7.8, mean 24.7, SD 7.6, mean 23.7, SD 7.6 
in clusters 1, 2, and 3, respectively, all p-values > 0.20). The impaired cluster did 
not include any patients with schizoaffective disorder, bipolar disorder or other 
affective psychotic disorders, while in the well-performing and intermediate 
clusters, these diagnoses were assigned to 14% and 11% of the subjects, 
respectively. About 36% of family members in all three clusters were unaffected. 
5.5.3 Neuropsychological variables 
The impaired cluster scored lowest in all measured neuropsychological variables, 
and the intermediate cluster showed consistently worse performance than the 
well-performing one. The differences between the family clusters in the 
neuropsychological variables were tested by the within-family linear mixed effect 
models (Study V, Table 4, page 9/13). In these models, the impaired cluster was 
found to achieve significantly lower scores than both other clusters in almost all 
traits. The only variable not reaching statistical significance in differentiating any 
of the clusters was auditory attention.  
5.5.4 Effect of education 
As the clusters differed significantly from each other in education years, we 
conducted post hoc linear mixed effects models with family as the fixed effect, 
and age, sex and education years as the random effects (data not shown). This did 
not eliminate the significant differences in cognitive functioning between the 
well-performing and the impaired cluster. In contrasts between the well-
performing and intermediate cluster, all other differences remained significant, 
except in the scores of Visual immediate recall, Digit Symbol, and Verbal 
fluency, which lost their significance. Between the intermediate and the impaired 
cluster, scores in Vocabulary and Digit Symbol were no longer significantly 
different after controlling for education years. 
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6   DISCUSSION 
The main aim of the present thesis was to explore whether quantitative traits 
derived from neuropsychological test data could be successfully used in a 
genomewide QTL-analysis of schizophrenia patients and their family members. 
Before coming to this aim, the cognitive test variables, collected from two 
population based samples with familial schizophrenia, were examined as to their 
heritability, and the number of their contributing loci was estimated. Furthermore, 
their association with familial loading in unaffected relatives, and the contribution 
of this loading on the effect of age at onset on the cognitive functions was 
examined. A genomewide linkage analysis including the neuropsychological test 
variables that were considered the most valid endophenotypes was then 
conducted. For further genetic studies that would benefit from using more 
homogeneous family data, a family-based cluster analysis was done in order to 
identify schizophrenia families with similar neuropsychological test performance 
among the affected and unaffected family members.    
6.1 ARE COGNITIVE DYSFUNCTIONS HERITABLE IN SCHIZOPHRENIA?
In the Study I, a sample of genealogically well-defined and genetically 
homogeneous families with schizophrenia was used to estimate the 
heritabilities of cognitive traits, and to detect the number of QTLs 
contributing to these traits. Significant additive heritability estimates were 
detected in several cognitive functions that reflect the encoding stage during 
verbal learning. The significantly heritable functions were using semantic 
clusters while recalling words from a word list, providing words that were not 
in the list (intrusive recall errors), recognition memory, verbal working 
memory, and verbal ability. In addition, the heritability estimate of visual 
working memory was marginally significant. Impairment in the functions 
during the encoding phase affects on maintenance and retrieval of 
information, which in turn may cause poor recognition memory and producing 
recall errors. Slowed encoding affects working memory and impairs the 
activation of mental representations essential for efficient working memory.  
Results in the Study I suggested that dysfunctional encoding was heritable in 
the studied families with schizophrenia. However, the outcome of verbal 
learning as measured by the total score of the recalled words in the word list 
test, showed only suggestive additive heritability in the present study sample, 
and the number of its contributing loci was dispersed. Still, verbal memory is 
among the most impaired functions in schizophrenia (Saykin et al 1991; 
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Heinrichs and Zakzanis 1998; Heinrichs 2004), and impairments are observed in 
the relatives of schizophrenia patients, too (Faraone et al 1995; Faraone et al 
1999a; Egan et al 2001a).    
Functions that related to working memory showed the most restricted number 
of loci, when these were estimated on a theoretical basis. These functions are 
assumed to reflect frontal lobe functioning and their connections to 
subcortical areas (Stuss and Benson 1987; Lezak et al 2004). The result 
suggested that genetic linkage analyses could benefit particularly from using 
the quantitative data derived from working memory test scores.  
The Study I showed that the cognitive traits relating to working memory and such 
verbal memory functions that associate with the primary encoding phase of 
learning, are at least modestly heritable in schizophrenia families and could be 
valuable endophenotypic traits in genetic analyses. Of particular interest would be 
the traits measuring working memory functions, as they were contributed by a 
very restricted number of loci in the theoretical estimation of their number.  
6.2 COGNITIVE FUNCTIONING IN THE HEALTHY RELATIVES OF SCHIZOPHRENIA 
PATIENTS: EFFECT OF FAMILIAL LOADING
In the Study II, only the unaffected relatives of the schizophrenia patients were 
included in the analysis. The subjects were divided into two groups according to 
the number of first-degree relatives with schizophrenia. The singleton group 
included healthy relatives with only one family member with schizophrenia, and 
the multiplex group included those with at least one relative with schizophrenia 
plus at least another with schizophrenia or other non-affective psychosis. The aim 
was to study whether individuals from multiplex families perform worse than 
individuals from singleton families on the cognitive tests. This difference would 
indicate the effect of familial loading. Only visual working memory showed such 
an association.  
In the study by Faraone et al (2000), relatives from singleton families scored 
worse than controls in immediate verbal memory, while controls outperformed 
the relatives from multiplex families in estimated intelligence, logical memory, 
and immediate visual reproductions. The relatives from multiplex families were 
worse than those from the singleton families in logical memory and immediate 
visual memory. The Study II did not find differences between the groups in 
verbal long-term memory, as the Faraone et al (2000) study did. They used the 
Logical Memory subtest from WMS-R, while we used the CVLT. The latter is 
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more than the former a measure of using strategies in verbal learning and memory 
rather than a measure of pure verbal memory, which may explain the different 
results.
However, results of the study accord partly with the finding in the Faraone et al 
(2000) study, in which females from multiply affected families were more 
impaired than females from the singleton families in verbal memory. In the 
present study, females from multiply affected families were found to use more 
primacy in learning word lists than females in the singleton families. High score 
in this type of serial clustering may indicate an uneffective learning strategy, 
which usually results in poor performance in other verbal memory tests (Delis et 
al 1987). It is also interesting to note, that in the Faraone et al (2000) study the 
second largest difference between the groups was detected in the immediate 
visual reproductions, whereas the delayed score was not significantly different. 
This may well represent visual working memory impairments in the multiplex 
group, which is in accordance with our results. 
Lacking a control group, the results of the Study II could only be compared with 
the mean of national normative data. It was observed that attention and working 
memory scores were lower than the norms in both groups, but significantly so only 
among the siblings from multiply affected families. As the study focused 
specifically on a sample of healthy siblings with no confounding effects of clinical 
psychiatric symptomatology or medication on neuropsychological performance, all 
subjects were free from any DSM-IV axis I or axis II psychiatric diagnosis. 
However, lack of completed diagnoses does not mean that certain psychiatric 
symptoms could not have been present. The results further supported the validity of 
the working memory functions, and visual working memory in particular, as 
valuable endophenotypic traits to be included in genetic linkage studies. 
6.3   VERBAL MEMORY DYSFUNCTION ASSOCIATES WITH EARLIER AGE OF ONSET 
OF SCHIZOPHRENIA 
Among 237 patients with schizophrenia, the effect of age of onset on cognitive 
functions was examined. In verbal memory as measured with the total score of 
recalled words in the CVLT (Delis et al 1987), in using semantic clusters as a 
learning strategy, in producing intrusive recall errors, and in recognition memory, 
worse performance associated with earlier age of onset.  
The results of the Study III were in line with previous studies. Verbal memory 
impairment has consistently been found to associate with earlier onset (Jeste et al 
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1998; Hambrecht et al 2002; Turetsky et al 2002). Impairments in verbal learning 
and memory tasks, found to be relatively most impaired in schizophrenia (Saykin 
et al 1991; Heinrichs and Zakzanis 1998; Heinrichs 2004), are probably present in 
the initial phase of the disorder. These functions also associate with the most 
complicated functional consequences of schizophrenia (Green 1996), and should 
be taken into account in the neuropsychological evaluation and efforts at 
remediation in patients with early-onset disorder.   
Furthermore, familial loading, as measured by the number of affected first-degree 
relatives, was included in additional models as a possible mediating factor for the 
effect of age of onset on cognitive functions, but the finding was negative. 
However, scores in visual working memory and verbal IQ were worse when there 
were more affected first-degree relatives in the family, irrespective of the age of 
onset. This result provides further support for the evidence of genetic influence 
on visual working memory dysfunction in families with schizophrenia.  
6.4 COGNITIVE TRAITS APPLIED IN A GENOMEWIDE QTL-ANALYSIS
The Study IV applied those quantitative cognitive traits that had previously been 
suggested as valuable endophenotypic variables in a genomewide QTL-based 
linkage analysis. The heritabilities of the included traits were found to be 
significant when reanalyzed in the process of the Study IV (data not shown). All 
included variables had also been found to associate with the vulnerability of the 
disorder in previous studies (Park et al 1995; Faraone et al 1999a; Cannon et al 
2000b; Egan et al 2000; Myles-Worsley and Park 2002).  
Analyses were run separately for the isolate (IS) and all Finland (AF) samples, 
and for the combined (Com) sample including both. The main interest was in the 
combined sample, in which the strongest evidence of linkage was obtained for 
verbal learning and memory functions as measured by the CVLT (Delis et al 
1987). The finding that verbal learning and semantic clustering were linked to 
the same chromosomal region was not surprising, since these traits correlate 
with each other. Previously, Egan et al (2001a) have detected that siblings of 
schizophrenia patients have a significant relative risk for impaired performance in 
verbal learning.  
The LOD score on chromosome locus 4q21, marker D4S2361, was 2.87 for 
semantic clustering, for delayed verbal memory 3.01, and 2.96 for verbal 
learning. The importance of this region was emphasized by the fact that evidence 
of linkage was found for other traits related to verbal learning strategies within a 
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30cM region on 4q13-25.  This region has also shown linkage in previous genetic 
analyses based on clinical diagnosis (Hovatta et al 1999).  
Visual working memory has been suggested as a valid quantitative trait in 
schizophrenia in many studies (Park et al 1995; Cannon et al 2000b; Myles-
Worsley and Park 2002), and results from the Studies I-III further supported this 
view. It has also been used successfully in the first actual QTL-analysis on 
chromosome 1q32 with cognitive test data among Finnish twins (Gasperoni et al 
2003). In the Studies II and III, it showed familial associations both in the 
unaffected family members and in the patients. In the genomewide linkage 
analysis of the Study IV, suggestive evidence for visual working memory was 
detected at chromosome 2q35-36, which is close to a locus detected in a previous 
linkage study comprising families from the isolate sample and with the diagnosis 
as the phenotype (Paunio et al 2001). No locus on the chromosome 1 showed 
linkage in the study IV, which may be caused by the genomewide approach not 
including all the essential markers.   
In the Study IV, which is the first published genomewide QTL-study on 
neuropsychological test variables used as endophenotypic traits, the linkage 
information was greatly accentuated by applying these traits as compared with 
using the clinical dichotomical diagnosis. The results not only confirm and extend 
previous linkage findings, but also demonstrate the benefit of using trait 
components instead of clinical diagnoses in genomewide hunt for genes involved 
in susceptibility to schizophrenia.  
6.5 COGNITIVE FUNCTIONING AS A BASIS FOR CLUSTERING FAMILIES WITH 
SCHIZOPHRENIA
The Study V included 54 families from the whole geographical area of Finland. 
In all families, there were at least two siblings with schizophrenia, schizoaffective 
psychosis or schizophreniform disorder, and their unaffected family members. In 
addition, some family members with affective psychotic disorders were included. 
The study aimed at identifying families with convergent neuropsychological test 
performance, including such test variables that in previous studies have been 
considered potential endophenotypic components in schizophrenia. The rationale 
for this effort was to allow selecting phenotypically more homogeneous groups of 
families for subsequent genetic analyses. For this aim, 17 neuropsychological test 
variables, plus age and sex were incorporated in a visually aided clustering 
algorithm. This process identified three clusters of families. The first cluster 
included 17 families with well-performing subjects, the cluster two comprised an 
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impaired cluster with 12 families, and the third was intermediate with a less clear 
performance profile in 25 families.  The clusters did not differ from each other in 
age, sex distribution, and, regarding the affected subjects, in the age of onset. The 
well-performing cluster was better educated than the other two, but covariating 
with education did not change the main results in comparing the cognitive test 
differences between the clusters.  
The three cluster solution was supported by the homogeneity of the within-group 
test performance pattern, and a visual exploration of the merging distance process 
(see Figures 2 and 3 in the Study V, pages 4/12 and 5/12).  
The diagnostic distribution among the patients was interesting, as all the patients 
in the impaired cluster suffered from schizophrenia, and no family members with 
affective psychotic disorders ended up into this cluster. It can thus be considered 
to represent a subsample of core schizophrenia with the most impaired cognitive 
functioning. This cluster included the same proportion of unaffected subjects as 
the two other clusters, and by the logic of the clustering algorithm, also the 
unaffected subjects performed poorly in this cluster. 
The Study V is the first one in which whole families with schizophrenia has been 
included in a clustering analysis. Previously, clusters comprising solely patients 
with schizophrenia have revealed similar groupings and the same number of 
clusters as ours (Sautter et al 1995; Hill et al 2002; Turetsky et al 2002). The results 
of the Study V will be exploited in further genomewide analyses, as well as 
associating them with candidate gene data derived from the present study sample.  
6.6 METHODOLOGICAL LIMITATIONS
Several limitations have to be noted. The study sample derived from a 
geographical isolate may limit the generalizability of the results of all Studies I-
V. In the Studies II and III, in which familial loading was operationalized as the 
number of first-degree relatives with psychotic disorders, the genetic isolate 
design allows considering only  horizontal loading effects, as there may have 
been vertical genetic connections between the families. This is particularly the 
case in the Study II, in which only the isolated sample from the northeastern part 
of Finland was included in the analyses. This study also suffered from the lack of 
a control group. Furthermore, although the subjects for the study project were 
randomly selected and carefully diagnosed, they mainly came from families with 
multiple members with schizophrenia spectrum disorders, which represent only 
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the fifth part of all schizophrenia cases. Thus the results may apply only when 
familial schizophrenia is concerned.    
Furthermore, the subjects in all studies I-V were rather aged, with the mean age 
generally over 45 years. Thus some of the dysfunctions observed may have 
reflected normal deterioration of cognitive function with increased age.  
However, age was controlled for in each study. The possible medication effects 
among the affected subjects was not controlled for in any of the studies 
comprising the present thesis. Many patients were on both typical and atypical 
neuroleptics, both of which may have enhancing or impairing effects on 
cognition. Furthermore, the use of anxiolytics and anticholinergics was common. 
In literature, no consent exists whether medication should be added as a 
confounding factor in the analyses, and the choice was made here not to take 
medication effects into account. 
Concerning the used neuropsychological tests, which were all well known and 
internationally used methods, and allow comparison between studies, some 
concerns arise.  This is particularly the case with the measures for attention, and 
the task that was used to assess visual working memory. The forward verbal or 
visual span tasks as measures of attention (Lezak et al 2004) may not have 
been sufficiently powerful for assessing this trait. Performance in specifically 
forward condition span tasks is suggested not to depend on the function of the 
prefrontal cortex (for a review, see D´Esposito and Postle, 1999). Generally, 
attention has been measured in many studies using versions of Continuous 
Performance Tests, which assess sustained attention (vigilance), or summary 
measures like Attention Deviance Index (Erlenmayer-Kimling and Cornblatt 
1992; Cornblatt and Keilp 1994; Cornblatt et al 1999; Erlenmayer-Kimling 
2000). It is possible that such measures would have given more interesting 
results concerning the genetic effects of attention in the present studies, too. 
The majority of studies on the visuospatial working memory in schizophrenia has 
employed the delayed response task (DRT) (e.g. Park et al 1995; Myles-Worsley 
and Park 2002), while only a few have used the visual span task as was done in 
the present studies (Cannon et al 2000b; Gasperoni et al 2003). The visual span 
subtest of the WMS-R (Wechsler 1987) is a complex task involving immediate 
memory, maintenance, memory of sequence, and a motor response, including 
volition to initiate the response. In addition, the task requires encoding-related 
processes (Glahn et al 2003), and storage processes of working memory 
(D'Esposito and Postle 1999). The motor planning to give the response may 
demand working memory as well (Saper et al 2000). Thus, the span test may be 
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reflecting interactions between subsystems or processes of working memory 
(Fischer 2001). However, the results of the present thesis showed that the 
backward visual span, which may require more central working memory (Chey et 
al 2002) was associated with genetic effects among the unaffected subjects (Study 
II), in the patients (Study III), and in combined samples (Studies I, IV and V).  
Furthermore, the test battery that was applied in the present thesis, did not include 
certain important measures that have shown genetic associations and could have 
produced valid endophenotypic variables. These include the Wisconsin Card 
Sorting Test (WCST, Heaton et al 1981), a measure of executive functioning, that 
has been succesfully used in the studies of the associations of the prefrontal 
cortex functioning and the COMT gene (e.g. Egan et al 2001b), although recently 
these results have not been replicated (Rosa et al 2004). Furthermore, certain 
novel computerized test paradigms, for example the n-back test assessing 
working memory functions, were not included.  However, all the included test 
measures covered those areas of functioning that have been found impaired in 
schizophrenia, i.e. attention, memory, and executive functioning.  
Although the heritability issue and the familial and genetic effects were 
approached from many angles, the fundamental criterion of an endophenotype - 
the heritability - was estimated when only a part of the targeted sample of 
families was collected. Thus, the heritability of neuropsychological test variables 
was estimated among 264 subjects, 171 affected and 93 unaffected, from 131 
families living at the Kuusamo isolate. If a larger sample would have been 
included, the heritability estimates would most probably have been higher. 
Moreover, it is possible that controlling for verbal ability in the heritability 
analyses of the Study I reduced the particularly the verbal memory estimates. 
Indeed, when the heritabilities were estimated again for the Study IV, with age 
and sex as the only covariates, markedly enhanced estimates were received (data 
not shown). This was particularly the case with verbal learning as measured by 
the CVLT total score in trials 1-5.  
It is not very well known how heritable the cognitive functions are among the 
general population. Heritability estimates associated with cognitive functions 
may reflect true biological factors, but their association with schizophrenia is 
not necessarily evidenced. Relatives share environments as well as genes. It is 
possible that other modeling with factors of bias potential (e.g. shared deviant 
rearing environment, assortative mating, or gene-environmental interaction) 
would have given different results and in part explain those features that were 
assumed to be genetically inherited in the Study I. 
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6.7 GENERAL DISCUSSION AND IMPLICATIONS FOR FURTHER RESEARCH
The cognitive functions that were included in the studies comprising the present 
thesis proved at least modestly heritable among a representative population 
sample of families with schizophrenia.  
The present study showed that particularly the cognitive traits associated with 
verbal learning and memory increased markedly the LOD scores of linkage 
compared with the use of categorical diagnosis. Although not very strong familial 
effects contributing to this trait were detected in the Studies I-III, it is 
unquestionably one of the most impaired cognitive functions in schizophrenia, 
and is also observed in non-psychotic relatives of the patients. The importance of 
the results is emphasized by the previous evidence of linkage, using the same 
study population, to the same region using the clinical diagnosis as the phenotype 
(Paunio et al 2001). However, the LOD scores received here were still moderate, 
suggesting that the traits assumed to be endophenotypes of schizophrenia proved 
out not to be highly sensitive at least on the markers included in the genomewide 
scan. Moreover, their specificity to schizophrenia remains unknown. Studies on 
the genetic factors of cognitive functions in other psychiatric family samples, and 
in the general population would be highly required for receiving reference data 
for further studies like the present one.  
Visual working memory was the variable that consistently showed familial and 
genetic effects in samples of both unaffected family members and patients with 
schizophrenia in the Studies I-III. However, the results in the present 
genomewide linkage analysis with data from 449 markers still left open questions 
of the validity of this cognitive endophenotype. Further hypothesis driven 
analyses, utilizing both the knowledge of the neurobiological basis of this 
function and denser marker data are warranted.  
Kéri and Janka (2004) have presented a critical approach on the use of cognitive 
dysfunctions as endophenotypes of schizophrenia. Identifying altogether 82 
relevant papers in a detailed review, they investigated the reliability and frequency 
of cognitive impairments in individuals with schizophrenia and their biological 
relatives. Kéri and Janka brought up the important fact that although a wide range 
of cognitive dysfunctions are present in patients as well as in their relatives, there 
exists a substantial proportion of patients and relatives with preserved cognition 
(Kéri and Janka 2004). Furthermore, Heinrichs (2004) in his important paper, states 
that although group differences suggest adequate temporal stability for many 
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biobehavioral measures, individual patients often fluctuate between impaired and 
unimpaired performance over time. Not all patients demonstrate trait-like 
performance, perhaps due to the nonspecific influence that may be transitory in 
nature (Heinrichs 2004). Kéri and Janka (2004) concluded that at present, cognitive 
dysfunctions can not be considered highly sensitive and specific endophenotypes. 
Indeed, there is evidence that e.g. executive dysfunction is observed both in 
schizophrenia and bipolar disorder. However, according to the review by Kéri and 
Janka (2004), elementary visual processing, verbal episodic memory, and spatial 
working memory seem to be among the most promising endophenotypic functions. 
The results of the present thesis, including the last two variables from this list, 
proved their promise at least on a modest level.  
Further QTL linkage studies with denser marker data, probably looking at one 
chromosome at a time, or association studies on the promising candidate genes of 
schzophrenia, are highly warranted. The preliminary QTL analysis, conducted by 
Gasperoni et al (2003) is one example of such a study. Our study group has 
conducted a hypothesis based association analysis using certain cognitive traits 
and the DISC1 gene and its associated haplotypes (Hennah et al, submitted), and 
even the two SNPs comprising one of the most interesting haplotype (Tuulio-
Henriksson et al 2004) with interesting results of these associations.   
Furthermore, future will show whether the cluster analysis aiming at detecting 
more homogeneous subgroups of families with schizophrenia will be fruitful in 
genomewise linkage analyses and candidate gene association analyses. A refined 
definition of the phenotype of schizophrenia may also be attained by including 
both neuropsychological and other clinical data simultaneously into clustering 
paradigms.   
Although the results of the present study do not produce direct clinical 
implications, they clearly show the importance of the clinical neuropsychological 
assessment of a schizophrenia patient. In fact, the last two decades during which 
the cognitive deficits in schizophrenia have been considered as one type of core 
symptoms of the disorder, implicate a neuropsychological assessment to a patient 
with schizophrenia should be a routine in clinical practice. Although this 
assessment may not be of help for the diagnosis, it has important contributions to 
understanding the course of cognitive impairment, as well as its relationship with 
the functional consequences of the disorder. For patients with early onset, and for 
the first-episode patients, this is of particular importance.  
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The studies comprising the present thesis stand for basic schizophrenia research 
aiming at giving tools for the research on the biological processes that lay behind 
the vulnerability to the disorder. Further studies on the neurobiology of the 
cognitive dysfunctions that have been shown to be familial, and possibly genetic, 
may lead to elucidating the genetic background of schizophrenia. Studies on the 
cognitive dysfunction in schizophrenia may help in understanding better the 
environmental and individual possibilities for preventing the psychosocial 
problems that still today are reality for too many patients with this disorder.  
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